8-K

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE)

8-K 2021-04-26 For: 2021-04-26
View Original
Added on April 01, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 26, 2021

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

Maryland 1-12993 95-4502084
(State or other jurisdiction of<br>incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

26 North Euclid Avenue, Pasadena, California 91101

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: (626) 578-0777

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐            Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.01 par value per share ARE New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.  Results of Operations and Financial Condition.

On April 26, 2021, Alexandria Real Estate Equities, Inc. (the “Company”) issued a press release entitled “Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2021 Financial and Operating Results.”  The press release referred to certain supplemental information that is available on the Company’s website at www.are.com.  A copy of the press release and supplemental information are attached hereto as Exhibit 99.1.

The information contained in this Item 2.02, including the exhibit referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section.  Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01.  Financial Statements and Exhibits.

(d)  Exhibits.

99.1     Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the First Quarter Ended March 31, 2021

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Forward-Looking Statements

This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act.  These statements include words such as “forecast,” “guidance,” “projects,” “estimates,” “anticipates,” “goals,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” or “will,” or the negative of these words or similar words.  Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement.  A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.  The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ALEXANDRIA REAL ESTATE EQUITIES, INC.
April 26, 2021 By: /s/ Joel S. Marcus
Joel S. Marcus
Executive Chairman
By: /s/ Stephen A. Richardson
Stephen A. Richardson
Co-Chief Executive Officer
By: /s/ Peter M. Moglia
Peter M. Moglia
Co-Chief Executive Officer and <br>Co-Chief Investment Officer
By: /s/ Dean A. Shigenaga
Dean A. Shigenaga
President and Chief Financial Officer

Document

q121frontcoverv41a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021

q121collinsquote1.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 i

q121inthenewsv11a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 ii

q121onefifteensplashv21a.jpg

(1)Source: JAMA Psychiatry, "Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic," February 3, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 iii

q121gateway685splashv21a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 iv

q121insidecoverv71a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 v

q121insidecoverdnav31a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 vi

q121metricsv71a.jpg

(1)Refer to “Annual rental revenue” and “Investment-grade or publicly traded large cap tenants” in the “Definitions and reconciliations” of our Supplemental Information for additional details.

(2)Liquidity as of March 31, 2021. Refer to “Key credit metrics” of our Supplemental Information for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 vii

q121balancesheetcoverv51a.jpg

(1)Represents credit rating levels from Moody’s Investors Service and S&P Global Ratings for publicly traded REITs (excluding mortgage REITs), from Bloomberg Professional Services as of March 31, 2021.

(2)As of March 31, 2021. Refer to “Key credit metrics” of our Supplemental Information for additional details.

(3)Quarter annualized.

(4)As of March 31, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 viii

q121socialresponsibilityv31a.jpg

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 ix

q121sustainabilityv61a.jpg

(1)13 projects have been certified and another 36 projects are in process targeting WELL or Fitwel certification.

(2)Source: Barron’s, “The 10 Most Sustainable REITs, According to Calvert,” February 19, 2021.

(3)Relative to a 2015 baseline for buildings in operation that Alexandria directly manages.

(4)For buildings in operation that Alexandria directly and indirectly manages.

(5)Reflects sum of annual like-for-like progress from 2015 to 2020.

(6)Reflects progress for all buildings in operation in 2020 that Alexandria directly and indirectly manages.

Alexandria Real Estate Equities, Inc. All Rights Reserved. ©2021 x
Table of Contents
---
March 31, 2021 EARNINGS PRESS RELEASE Page Page
--- --- --- ---
First Quarter Ended March 31, 2021, Financial and Operating Results 1 Earnings Call Information and About the Company 13
Alexandria and Our Innovative Tenants 6 Consolidated Statements of Operations 14
Acquisitions 9 Consolidated Balance Sheets 15
Dispositionsand Sale of Partial Interest 10 Funds From Operations and Funds From Operations per Share 16
Guidance 11
SUPPLEMENTAL INFORMATION Page Page
Company Profile 19 External Growth / Investments in Real Estate
Investor Information 20 Investments in Real Estate 38
Financial and Asset Base Highlights 21 New Class A Development and Redevelopment Properties:
High-Quality, Diverse, and Innovative Tenants 23 Recent Deliveries 39
Class A Properties in AAA Locations 24 Current Projects 40
Occupancy 25 Summary of Pipeline 44
Internal Growth Construction Spending 47
Key Operating Metrics 26 Joint Venture Financial Information 48
Same Property Performance 27 Balance Sheet Management
Leasing Activity 28 Investments 50
Contractual Lease Expirations 29 Key Credit Metrics 51
Top 20 Tenants 30 Summary of Debt 52
Summary of Properties and Occupancy 31 Definitions and Reconciliations
Property Listing 32 Definitions and Reconciliations 55

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Please refer to page 13 of this Earnings Press Release and our Supplemental Information for further information.

This document is not an offer to sell or a solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy our securities shall be made only by means of a prospectus approved for that purpose. Unless otherwise indicated, the “Company,” “Alexandria,” “ARE,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and our consolidated subsidiaries.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 xi

logo1a.jpg

Alexandria Real Estate Equities, Inc.

Reports:

1Q21 Net Income per Share – Diluted of $0.04;

1Q21 FFO per Share – Diluted, As Adjusted, of $1.91; and

Alexandria at the Vanguard and Heart of the Life Science Ecosystem

PASADENA, Calif. – April 26, 2021 – Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2021.

Key highlights
Operating results 1Q21 1Q20
Total revenues:
In millions $ 479.8 $ 439.9
Growth 9.1 %
Net income attributable to Alexandria’s common stockholders – diluted
In millions $ 6.1 $ 16.8
Per share $ 0.04 $ 0.14
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted
In millions $ 263.0 $ 221.4
Per share $ 1.91 $ 1.82

Alexandria and our tenants at the vanguard and heart of the life science ecosystem

Bringing together our unique and pioneering vertical platforms of essential Labspace® real estate, strategic venture investments, impactful thought leadership, and purposeful corporate responsibility, Alexandria is at the vanguard and heart of the vital life science ecosystem that is solving COVID-19 with unprecedented speed and efficiency while addressing other major challenges to human health. Owing to the efforts of numerous Alexandria tenants, including Pfizer Inc., Moderna, Inc., and Johnson & Johnson, in developing and delivering safe and effective vaccines and therapies to people around the world, the inherent value of and critical need for the life science industry have been globally recognized. As we entered this new year, the essential R&D engine of the biopharma industry continued to perform with exceptional productivity, progress, and resilience. By maintaining 24/7 operations across our campuses and facilities, Alexandria enables our tenants to pursue their mission-critical research, development, manufacturing, and commercialization efforts to solve these most pressing current and future healthcare challenges.

Strong and flexible balance sheet with significant liquidity

•Investment-grade credit ratings ranked in the top 10% among all publicly traded REITs as of March 31, 2021.

•Net debt and preferred stock to Adjusted EBITDA of 5.8x for 1Q21 annualized.

•Fixed-charge coverage ratio of 4.7x for 1Q21 annualized.

•$4.3 billion of liquidity as of March 31, 2021.

•No debt maturities prior to 2024.

•13.0 years weighted-average remaining term of debt as of March 31, 2021.

Continued dividend strategy to share growth in cash flows with stockholders

Common stock dividend declared for 1Q21 of $1.09 per common share, aggregating $4.30 per common share for the twelve months ended March 31, 2021, up 24 cents, or 6%, over the twelve months ended March 31, 2020. Our FFO payout ratio of 60% for the three months ended March 31, 2021, allows us to share growth in cash flows from operating activities with our stockholders while also retaining a significant portion for reinvestment.

A REIT industry-leading, high-quality tenant roster

•55% of annual rental revenue from investment-grade or publicly traded large cap tenants.

•Weighted-average remaining lease term of 7.6 years.

Key development projects placed into service in 1Q21

We placed into service three fully leased development projects aggregating 376,475 RSF located across three submarkets at a weighted-average yield of 6.6% and 6.3% (cash basis).

Key strategic transaction that generated capital for investment into our highly leased value-creation pipeline

In April 2021, we sold a 70% partial interest in our 213 East Grand Avenue property located in our South San Francisco submarket for a sales price of $301.0 million, or $1,429 per RSF, representing capitalization rates of 4.5% and 4.0% (cash basis), which generated capital for investment into our highly leased development and redevelopment projects and strategic acquisitions.

Continued strong net operating income and internal growth

•Net operating income (cash basis) of $1.2 billion for 1Q21 annualized, up $112.8 million, or 10.3%, compared to 1Q20 annualized.

•95% of our leases contain contractual annual rent escalations approximating 3%.

•4.4% and 6.1% (cash basis) same property net operating income growth for 1Q21 over 1Q20.

•Continued strong leasing activity and rental rate growth during 1Q21 over expiring rates on renewed and re-leased space:

1Q21
Total leasing activity – RSF 1,677,659 (1)
Leasing of development and redevelopment space – RSF 788,973
Lease renewals and re-leasing of space:
RSF (included in total leasing activity above) 521,825
Rental rate increases 36.2%
Rental rate increases (cash basis) 17.4%

(1)Represents the second highest quarterly leasing activity during the past five years.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 1 | | --- | --- || First Quarter Ended March 31, 2021, Financial and Operating Results (continued) | | --- | | March 31, 2021 |

High-quality revenues and cash flows, strong margins, and operational excellence

Percentage of annual rental revenue in effect from investment-grade or publicly traded large cap tenants 55 %
Occupancy of operating properties in North America 94.5 % (1)
Operating margin 71 %
Adjusted EBITDA margin 69 %
Weighted-average remaining lease term:
All tenants 7.6 years
Top 20 tenants 10.9 years

(1)Includes 1.2 million RSF, or 3.5%, of vacancy at recently acquired properties in our North America markets, representing lease-up opportunities that will contribute to growth in cash flows. Approximately 26% of the vacant 1.2 million RSF is currently leased, with occupancy expected primarily over the next two quarters. Excluding these acquired vacancies, occupancy of operating properties in North America was 98.0% as of March 31, 2021. Refer to “Occupancy” of our Supplemental Information for additional details.

Sustained strength in tenant collections during the ongoing COVID-19 pandemic

•Tenant collections remain consistently high, with 99.4% of April 2021 billings collected as of the date of this release.

•As of March 31, 2021, our tenant receivables balance was $7.6 million.

Key items included in operating results

Key items included in net income attributable to Alexandria’s common stockholders:
(In millions, except per share amounts) Amount Per Share – Diluted
1Q21 1Q20 1Q21 1Q20
Unrealized losses on non-real estate investments $ (46.3) $ (17.1) $ (0.34) $ (0.14)
Realized gains on non-real estate investments 22.9 (1) 0.17
Gain on sales of real estate 2.8 (1) 0.02
Impairment of real estate (5.1) (1) (9.6) (0.04) (0.08)
Impairment of non-real estate investments (19.8) (0.16)
Loss on early extinguishment of debt (67.3) (1) (0.49)
Total $ (93.0) $ (46.5) $ (0.68) $ (0.38)

(1)Refer to “Funds from operations and funds from operations per share” of this Earnings Press Release for additional details.

Strategic acquisitions with significant value-creation opportunities in key submarkets

•During 1Q21, we completed the acquisition of 25 properties in key submarkets aggregating 3.1 million SF, including 1.8 million RSF from our acquisition of Alexandria Center® for Life Science – Fenway (described below), for an aggregate purchase price of $1.9 billion. All of these transactions included development and/or redevelopment opportunities. Additionally, some of the value-creation-related acquisitions also included one or more operating properties.

Acquisition of 401 Park Drive and 201 Brookline Avenue

•During 1Q21, we acquired the Alexandria Center® for Life Science – Fenway, located in our Fenway submarket, for a purchase price of $1.48 billion. The future collaborative life science campus, aggregating 1.8 million SF, consists of the following as of March 31, 2021:

•401 Park Drive (operating property with future redevelopment opportunity):

•Highly amenitized Class A office/R&D building aggregating 973,145 RSF is 90% occupied with a weighted-average remaining lease term of 8.4 years;

•56% of annual rental revenue is generated from investment-grade tenants;

•In-place rents are 38% below market; 30% of the RSF has a weighted-average remaining lease term of 3.1 years with in-place rents approximately 41% below market;

•Initial stabilized yields of 5.7% and 4.5% (cash basis); and

•Future opportunity to convert up to 311,066 RSF of office space, or 32% of the building, to office/laboratory space through redevelopment.

•201 Brookline Avenue (active development project):

•Office/laboratory building undergoing ground-up development, aggregating 510,116 RSF, targeting initial occupancy in 2022;

•84% is leased/negotiating to high-quality tenants; and

•We have a 97.9% ownership interest in this project.

•Future development opportunity for one office/laboratory building for which we are pursuing entitlement rights approximating 305,000 SF of office/laboratory along with retail and amenity spaces.

Highly leased value-creation pipeline

•Current and pre-leased near-term projects aggregating 4.2 million RSF are currently in progress. These projects are highly leased/negotiating at 76%, including RSF already in service, and will generate significant revenues and cash flows.

•During 1Q21, we commenced development and redevelopment of five projects aggregating 1.0 million RSF, which are currently 73% leased/negotiating.

•Fully leased development projects placed into service during 1Q21:

•176,832 RSF leased to REGENXBIO Inc. at 9804 Medical Center Drive in our Rockville submarket;

•100,086 RSF leased to Adaptive Biotechnologies Corporation at 1165 Eastlake Avenue East in our Lake Union submarket; and

•99,557 RSF leased to Atreca, Inc. at the Alexandria Center® for Life Science – San Carlos in our Greater Stanford submarket.

•Annual net operating income (cash basis) is expected to increase by $26 million upon the burn-off of initial free rent from recently delivered projects.

Balance sheet management

Key metrics as of March 31, 2021

•$32.5 billion of total market capitalization.

•$23.9 billion of total equity capitalization.

•$4.3 billion of liquidity.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 2 | | --- | --- || First Quarter Ended March 31, 2021, Financial and Operating Results (continued) | | --- | | March 31, 2021 |

Key metrics as of March 31, 2021 (continued)

1Q21 Goal
Quarter Trailing 4Q21
Annualized 12 Months Annualized
Net debt and preferred stock to Adjusted EBITDA 5.8x 6.1x Less than or equal to 5.2x
Fixed-charge coverage ratio 4.7x 4.4x Greater than or equal to 4.8x Value-creation pipeline of new Class A development and redevelopment projects as a percentage of gross investments in real estate 1Q21
--- ---
Current and pre-leased near-term projects 76% leased/negotiating 9%
Income-producing/potential cash flows/covered land play(1) 6%
Land 4%

(1)Includes projects that have existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating campuses.

Key capital events

•During 1Q21, our common equity transactions included the following:

•In January 2021, we entered into forward equity sales agreements to sell an aggregate of 6.9 million shares of our common stock (including the exercise of underwriters’ option) aggregating $1.1 billion, at a public offering price of $164.00 per share, before underwriting discounts and commissions.

•In 1Q21, we settled a portion of our forward equity sales agreements by issuing 5.4 million shares and received net proceeds of $850.5 million.

•We expect to issue 1.5 million shares to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $232.6 million in 2021.

•In February 2021, we entered into a new ATM common stock offering program, which allows us to sell up to an aggregate of $1.0 billion of our common stock.

•In 1Q21, we issued 3.1 million shares under our ATM program at a price of $163.26 per share (before underwriting discounts) and received net proceeds of $492.3 million.

•As of April 26, 2021, the remaining aggregate amount available under our ATM program for future sales of common stock is $500.0 million.

•We issued the remaining 362 thousand shares of common stock to settle our forward equity sales agreements that were outstanding as of December 31, 2020, and received net proceeds of $56.2 million.

•In February 2021, we opportunistically issued $1.75 billion of unsecured senior notes payable with a weighted-average interest rate of 2.49% and a weighted-average maturity of 20.4 years. The unsecured senior notes include:

•$850.0 million of 3.00% unsecured senior notes due 2051.

•$900.0 million of 2.00% unsecured senior notes due 2032 expected to be allocated to eligible green projects.

•These proceeds were initially used to refinance our $650.0 million unsecured senior notes payable due in 2024, bearing an interest rate of 4.00%.

•As a result of this refinancing, we recognized a loss on early extinguishment of debt of $67.2 million, including the write-off of unamortized loan fees and premiums.

Investments

•Our investments in publicly traded companies and privately held entities aggregated a carrying amount of $1.6 billion, including an adjusted cost basis of $912.4 million and unrealized gains of $729.4 million, as of March 31, 2021.

•Investment income of $1.0 million for 1Q21 included $47.3 million in realized gains and $46.3 million in unrealized losses.

Subsequent events

•In April 2021, we acquired One Investors Way, located in our Route 128 submarket of Greater Boston, aggregating 240,000 RSF, for a purchase price of $105.0 million. The property was simultaneously 100% leased to Moderna, Inc. for 12 years and immediately placed into redevelopment. The property also includes a future development opportunity aggregating 350,000 RSF.

Industry and corporate responsibility leadership: catalyzing and leading the way for positive change to benefit human health and society

Industry leadership

•In February 2021, Alexandria was ranked as the third most sustainable REIT, as featured in Barron’s “The 10 Most Sustainable REITs, According to Calvert.”

•In March 2021, Alexandria LaunchLabs® at the Alexandria Center® at One Kendall Square in our Cambridge submarket was awarded the Fitwel Impact Award for achieving the highest-scoring project of all time. This is the second year in a row that Alexandria has held this distinction, demonstrating our unwavering commitment to optimizing projects to advance health and wellness.

•In January 2021, Alexandria Venture Investments, our strategic venture capital platform, was recognized for a fourth consecutive year as the most active biopharma corporate investor by new deal volume by Silicon Valley Bank in its “Healthcare Investments and Exits: Annual Report 2021.” In February 2021, Alexandria Venture Investments was also recognized as one of the five most active U.S. investors in agrifoodtech by deal volume in 2020 by AgFunder in its “2021 AgFunder AgriFoodTech Investment Report.”

Relentless drive to develop and implement disruptive and highly impactful solutions to society’s most urgent challenges

Against the backdrop of the ongoing COVID-19 pandemic, which has exacerbated persistent, preexisting societal challenges, and rooted in our mission to advance human health, Alexandria continues to work steadfastly to leverage our leadership, knowledge, expertise, and resources not only to combat the COVID-19 pandemic but also to create long-term scalable solutions to our most pressing societal challenges. This work includes national and regional efforts in the following areas, as further described below:

•Accelerating groundbreaking medical research, development, and manufacturing to advance lifesaving treatments and cures

•Harnessing the agrifood ecosystem to combat hunger, improve nutrition, and support human health at its most fundamental level

•Bolstering the resilience of our military, our veterans, and their families

•Conquering the opioid epidemic and revolutionizing addiction treatment

•Educationally empowering underserved students to achieve long-term success and reach their potential as leaders in the community

•Building a model for a comprehensive, sustainable solution to address homelessness

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 3 | | --- | --- || First Quarter Ended March 31, 2021, Financial and Operating Results (continued) | | --- | | March 31, 2021 |

Accelerating groundbreaking medical research, development, and manufacturing to advance lifesaving treatments and cures

•Alexandria is a critical driver of medical progress and provides transformative strategic funding to speed the most promising breakthrough biomedical discoveries from laboratories to patients in need.

•Our ongoing partnership with the Parker Institute for Cancer Immunotherapy (“PICI”) is a key example of our significant efforts in this area. As a sustaining supporter of PICI, Alexandria supports mission-critical work to develop breakthrough immunotherapies that could turn cancers into curable diseases faster. Serving on PICI’s Board of Directors, our Executive Chairman and Founder, Joel S. Marcus, helped guide PICI toward achieving many accomplishments in 2020, including the development of a first-of-its-kind data analysis engine for scientific discovery.

Harnessing the agrifood ecosystem to combat hunger, improve nutrition, and support human health at its most fundamental level

•Driven by the understanding that food is a fundamental building block of human health and well-being, Alexandria is dedicated to ensuring all Americans have the nutritious, healthy food they need to thrive. Through the support of partners like Alexandria for hunger-relief organizations, including Project Angel Food, Nourish Now, Los Angeles Regional Food Bank, and Feeding America, these non-profits have provided over 6 billion meals to hungry Americans during the pandemic.

•In Cambridge, we are long-term supporters of Food For Free, a non-profit organization dedicated to providing the Greater Boston community with reliable access to fresh and nutritious food. In February 2021, Alexandria announced its contribution toward Food For Free’s new Just Eats Grocery Box program. The program, which aims to distribute 3,000 boxes of food per week through food pantries, Cambridge Housing Authority sites, other low-income housing sites, and schools, fills a critical gap for food-insecure families in Greater Boston.

•Additionally, through our agtech real estate infrastructure and investments in innovative agtech companies, we continue to help combat hunger and improve nutrition for countless people facing food insecurity.

Bolstering the resilience of our military, our veterans, and their families

•With profound appreciation for the immense sacrifices of our nation’s heroes and the essential role they play in enabling us to pursue our noble mission, Alexandria is committed to providing resources to assist our military, our veterans, and their families to live healthy, successful, and rewarding lives. We have actively supported the Navy SEAL Foundation since 2010, including through our record-breaking fundraising efforts as the chair of the New York City Benefit in 2017 and as the recipient of its prestigious Patriot Award in 2020.

•Motivated to continue to enhance our critical support of the U.S. military, Alexandria joined The Honor Foundation (“THF”) and its founding partner, the Navy SEAL Foundation, in 2017, to embark on a truly impactful partnership to create a mission-critical headquarters in San Diego for THF, a unique career transition program for the Special Operations Forces community that effectively translates elite military experience to the private sector and helps facilitate the next generation of corporate and community leaders. Alexandria conceived of, designed, fully built out, and donated the use of an 8,000 RSF state-of-the-art facility where our nation’s most elite service members can participate in a tuition-free three-month executive education program that provides tools and experiences to help them transition from the Special Operations Forces to their next mission in life.

•In 2020, THF served over 1,350 service members at its world-class headquarters, up from 802 in 2019, and graduated 296 of our nation’s heroes from the program, up from 178 in 2019.

Conquering the opioid epidemic and revolutionizing addiction treatment: OneFifteen, a blueprint for the nation

•Determined to reverse the trajectory of the U.S. opioid epidemic, which is one of the most pervasive public health challenges in our nation’s history, Alexandria has built a partnership with Verily Life Sciences to create OneFifteen, an innovative, non-profit healthcare ecosystem dedicated to the full and sustained recovery of people living with addiction. Together, we pioneered a fully integrated campus in Dayton, Ohio, that houses an evidence-based model encompassing a full continuum of care with dedicated facilities and services for crisis stabilization, medication-assisted treatment, residential housing, peer support, family reunification, workforce development, job placement, and community transition.

•OneFifteen’s first-of-its-kind campus ecosystem was featured as the cover story in the January/February 2021 issue of REIT Magazine. The piece highlights our leadership role in this meaningful endeavor.

•Since June 2019, we completed construction of the OneFifteen Outpatient Clinic; the Crisis Stabilization Unit; and most recently, OneFifteen Living, the residential housing component that was delivered in September 2020.

•Overdose deaths continue to rise dramatically during the COVID-19 pandemic, demonstrating the tremendous need for the OneFifteen ecosystem. Since opening in the fall of 2019, OneFifteen has made a positive impact on the local community and the way addiction is treated, seeing approximately 2,700 patients, including over 1,300 people during the three months ended March 31, 2021. It is our hope that OneFifteen’s holistic approach to data-driven treatment will serve as a model of recovery for the rest of the country to replicate.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 4 | | --- | --- || First Quarter Ended March 31, 2021, Financial and Operating Results (continued) | | --- | | March 31, 2021 |

Educationally empowering underserved students to achieve long-term success and reach their potential as leaders in the community

•Understanding that education is one of the most fundamental foundations for a safe and healthy life, Alexandria is deeply committed to driving educational opportunities and providing the support and resources needed to prepare students for academic success, the 21st century job market, and a productive, rewarding life.

•In February 2021, we made a $2 million community benefit gift to the San Francisco Unified School District (“SFUSD”) to support the development of a new science-focused school in our Mission Bay submarket. In addition to this gift, which extends Alexandria’s impactful collaboration with SFUSD, we will provide our laboratory design, construction, and development expertise to the project; participate in shaping the academic program; and facilitate connections with the local life science community to enhance the school’s STEM education opportunities.

Building a model for a comprehensive, sustainable solution to address homelessness

•Inspired by the OneFifteen platform, we are presently incubating a similar model to combat homelessness in Seattle with the goal of providing a complete continuum of services in a safe living environment, from treatment for addiction and mental health issues to job training and placement.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 5

q121tenantscovidav71a.jpg

Represents an illustrative subset of approximately 100 tenants that have focused on COVID-19-related efforts, with some of these companies working on multiple efforts that span testing, treatment, and/or vaccine development.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 6

q121tenantscovidbv61a.jpg

(1)Source: U.S. Congressional Research Service, "Operation Warp Speed Contracts for COVID-19 Vaccines and Ancillary Vaccination Materials," Updated March 1, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 7
Alexandria Fighting COVID-19 on Multiple Fronts
---
March 31, 2021

Alexandria and our innovative tenants are at the vanguard and heart of the life science ecosystem solving COVID-19 with unprecedented speed and efficiency

Safe and effective vaccines and therapies, in addition to widespread testing, continue to be critically needed to bring an end to the global COVID-19 pandemic. By maintaining essential continuous operations across our campuses, Alexandria has enabled several of our life science tenants to pursue mission-critical COVID-19-related research and development. This heroic work by our tenants and campus community members to help test for, treat, and prevent COVID-19, as well as to provide medical supplies to neighboring hospitals, is profound and inspiring. We are currently tracking approximately 100 tenants across our cluster markets that have contributed meaningful time and resources to advancing solutions for COVID-19.

Developing preventative vaccines

Since the novel coronavirus’s genetic makeup was revealed in January 2020, researchers around the world have been working with unprecedented speed to develop safe and effective vaccines. To expedite the development, manufacturing, and distribution of these vaccines, the U.S. government called for broad public-private collaboration and allocated several billions of dollars to these efforts.

This support, along with the internal vaccine development expertise and innovative technology platforms of our tenants Pfizer Inc. (in partnership with BioNTech) and Moderna, Inc. (in partnership with the National Institutes of Health), culminated in the Food and Drug Administration’s (“FDA”) issuance of Emergency Use Authorization (“EUA”) in December 2020 for their respective mRNA-based COVID-19 vaccines. In February 2021, the FDA granted an EUA to Johnson & Johnson for its one-shot vaccine. The U.S. has initiated a large-scale COVID-19 vaccination campaign and will continue to roll out vaccines across the nation, with the goal of having adequate supply for the entire U.S. adult population by the end of May 2021.

Additional tenants, including AstraZeneca plc, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline plc, Novavax, Inc., and Sanofi, have similarly received strong government support for their efforts in the development, manufacturing, and/or distribution of COVID-19 vaccines. Many of these companies will report critical trial data over the coming months, which, if positive, could help further bolster the widespread distribution of safe and effective COVID-19 vaccines around the world.

Advancing new and repurposed therapies

Safe and effective therapies are important for mitigating the impact of COVID-19, decreasing hospitalizations, and improving patient outcomes overall. On October 22, 2020, the FDA approved Veklury® (remdesivir), developed by our tenant Gilead Sciences, Inc., as the first antiviral treatment approved for COVID-19 patients requiring hospitalization. Subsequently, in November 2020, the FDA granted EUAs to tenant Eli Lilly and Company’s bamlanivimab for the treatment of newly infected high-risk patients with mild or moderate disease, as well as to Regeneron Pharmaceutical’s antibody cocktail for a similar indication. In February 2021, Eli Lilly and Company received an additional EUA for its bamlanivimab + etesevimab COVID-19 antibody cocktail. In April 2021, due to observations of diminishing responsiveness of bamlanivimab alone to COVID-19 variants, Eli Lilly and Company requested that the FDA revoke its single antibody EUA and instead encourage use of their combination (bamlanivimab + etesevimab) antibody cocktail for COVID-19 patients at high risk of severe disease progression.

In addition, over 300 experimental therapies to treat COVID-19 are being studied in over 1,000 clinical trials around the world, and over 200 therapeutic candidates are in preclinical development. A substantial number of these programs are sponsored by our tenants, including the following:

•Vir Biotechnology, Inc. and GlaxoSmithKline plc announced on March 26, 2021, that they submitted an EUA request to the FDA for VIR-7831, their most advanced antibody therapy for the early treatment of adolescent and adult patients with mild to moderate COVID-19 risk for progression to hospitalization or death.

•AbbVie Inc., Amgen Inc., AstraZeneca plc, Atreca Inc., Merck & Co., Inc., Novartis AG, and Pfizer Inc. are similarly endeavoring to develop novel therapies and repurpose existing and investigational drugs to provide near-term treatments for moderate and severe COVID-19 patients and those at highest risk.

Improving testing quality and capacity

Abbott Laboratories, Adaptive Biotechnologies Corporation, Color, Cue Health Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Quidel Corporation, Roche, Thermo Fisher Scientific Inc., Verily Life Sciences, and others are working to improve testing quality, capacity, and turnaround time to more effectively determine who has an active COVID-19 infection, who has been exposed to the virus, and who has developed immunity against it. Even as vaccine distribution increases, the availability of widespread COVID-19 testing will remain critical for rapidly identifying new outbreaks and ultimately bringing the pandemic to an end.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 8
Acquisitions
---
March 31, 2021
(Dollars in thousands)
Property Submarket/Market Date of<br>Purchase Number of Properties Operating<br>Occupancy Square Footage Purchase Price
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Acquisitions with Development/Redevelopment Opportunities
Future Development Active Development/Redevelopment Operating With Future Development/ Redevelopment Operating(1) Operating
Completed in 1Q21:
Alexandria Center® for Life Science – Fenway Fenway/Greater Boston 1/29/21 2 90% (2) 305,000 510,116 311,066 662,079 $ 1,483,200 (2)
840 Winter Street Route 128/Greater Boston 1/20/21 1 100% 130,000 30,009 58,126 (3)
Other Various Various 22 97% 69,426 209,295 120,000 661,159 (4) 332,424
25 94% 374,426 849,411 431,066 1,353,247 1,873,750
Completed in April 2021:
550 Arsenal Street Cambridge/Inner Suburbs/Greater Boston 4/21/21 1 98% 515,000 260,867 130,000 (3)
One Investors Way Route 128/Greater Boston 4/6/21 1 100% 350,000 240,000 (5) 105,000 (3)
Other Various Various 1,535,000 92,534
327,534
Pending acquisitions:
Mercer Mega Block Lake Union/Seattle 2021(6) N/A 800,000 143,500
TBD 705,216
2021 acquisitions $ 3,050,000
2021 guidance range 2,800,000 – 3,300,000

All values are in US Dollars.

(1)Represents the operating component of our value-creation acquisitions that is not expected to undergo development or redevelopment.

(2)The campus includes an operating property with future redevelopment opportunities at 401 Park Drive, a development project at 201 Brookline Avenue, and a future development opportunity. 401 Park Drive, aggregating 973,145 RSF, is 90% occupied, with an additional 3% of leased space that is under renovation, and has initial stabilized yields of 5.7% and 4.5% (cash basis). We expect to provide total estimated costs and related yields for the development projects at 201 Brookline Avenue and the future development/redevelopment opportunities in the future, subsequent to the commencement of construction. Refer to “New Class A development and redevelopment properties: current projects” in our Supplemental Information for additional details.

(3)We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction. Refer to “New Class A development and redevelopment properties: current projects” in our Supplemental Information for additional details on active development and redevelopment projects.

(4)Represents the acquisition of our partner’s 43.2% ownership interest in our previously unconsolidated real estate joint venture at 704 Quince Orchard Road for $9.4 million. We completed the redevelopment of this stabilized property in 2Q19.

(5)Upon acquisition of this property, we entered into a 12-year lease with Moderna, Inc. and immediately placed the property into redevelopment.

(6)We continue to diligently work through various long-lead-time due diligence items, with certain deadlines extending into 2021. We are working toward completion of all due diligence items as soon as possible.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 9
Dispositions and Sale of Partial Interest
---
March 31, 2021
(Dollars in thousands)
Square Footage Capitalization Rate(Cash Basis)(1) Sales Price per RSF
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Property Submarket/Market Date of Sale Interest Sold Operating Future Development Capitalization Rate(1) Sales Price Gain
Completed in 1Q21:
Land Other/San Diego 3/12/21 100% 185,000 N/A N/A N/A $ 19
Completed in April 2021:
213 East Grand Avenue South San Francisco/San Francisco Bay Area 4/22/21 70% 300,930 4.5 % 4.0 301,000 $ 1,429 (2)
2021 guidance range 1,250,000 1,500,000

All values are in US Dollars.

(1)Capitalization rates are calculated based upon net operating income and net operating income (cash basis) annualized for the quarter preceding the date on which the property is sold.

(2)In April 2021, we completed the sale of a 70% partial interest in 213 East Grand Avenue in our South San Francisco submarket for a sales price of $301.0 million, or $1,429 per RSF, representing capitalization rates of 4.5% and 4.0% (cash basis). We retained control over the newly formed real estate joint venture and therefore continued to consolidate this property. We accounted for the $103.7 million difference between the consideration received and the book value of the 70% interest sold as an equity transaction, with no gain or loss recognized in earnings.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 10
Guidance
---
March 31, 2021
(Dollars in millions, except per share amounts)

The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2021. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. Also, refer to our discussion of “forward-looking statements” on page 13 of this Earnings Press Release for additional details.

Projected 2021 Earnings per Share and Funds From Operations per Share Attributable to Alexandria’s Common Stockholders – Diluted
As of 4/26/21 As of 2/1/21
Earnings per share(1) 1.58 to 1.68 2.14 to 2.34
Depreciation and amortization of real estate assets
Gain on sales of real estate(2)
Impairment of real estate – rental properties(2)
Allocation to unvested restricted stock awards
Funds from operations per share(3) 7.07 to 7.17 7.60 to 7.80
Unrealized losses on non-real estate investments
Realized gains on non-real estate investments(2)
Loss on early extinguishment of debt(4)
Allocation to unvested restricted stock awards
Other
Funds from operations per share, as adjusted(3) 7.68 to 7.78 7.60 to 7.80
Midpoint 7.73 7.70

All values are in US Dollars.

As of 4/26/21 As of 2/1/21
Key Assumptions Low High Low High
Occupancy percentage in North America as of December 31, 2021(5) 95.3% 95.9% 95.6% 96.2%
Lease renewals and re-leasing of space:
Rental rate increases 30.0% 33.0% 29.0% 32.0%
Rental rate increases (cash basis) 17.0% 20.0% 16.0% 19.0%
Same property performance:
Net operating income increase 1.5% 3.5% 1.0% 3.0%
Net operating income increase (cash basis) 4.3% 6.3% 4.0% 6.0%
Straight-line rent revenue $ 114 $ 124 $ 114 $ 124
General and administrative expenses $ 146 $ 151 $ 146 $ 151
Capitalization of interest $ 172 $ 182 $ 167 $ 177
Interest expense $ 128 $ 138 $ 133 $ 143

(1)Excludes unrealized gains or losses after March 31, 2021, that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.

(2)Refer to “Funds from operations and funds from operations per share” of this Earnings Press Release for additional details.

(3)Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in “Definitions and reconciliations” of our Supplemental Information for additional details.

(4)Refer to “Key capital events” on page 3 of this Earnings Press Release for additional details on the the refinancing of our $650.0 million unsecured senior notes payable.

(5)Updated guidance for occupancy percentage in North America as of December 31, 2021, reflects vacancy at the recently acquired property at the Alexandria Center® for Life Science – Fenway, representing lease-up opportunities that will contribute to growth in cash flows. Refer to “Occupancy” of this Supplemental Information for additional details.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 11 | | --- | --- || Guidance (continued) | | --- | | March 31, 2021 | | (Dollars in millions) | | Key Credit Metrics | As of 4/26/21 | As of 2/1/21 | | --- | --- | --- | | Net debt and preferred stock to Adjusted EBITDA – 4Q21 annualized | Less than or equal to 5.2x | Less than or equal to 5.2x | | Fixed-charge coverage ratio – 4Q21 annualized | Greater than or equal to 4.8x | Greater than or equal to 4.5x | | | As of 4/26/21 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Key Sources and Uses of Capital | Range | | | | Midpoint | | Certain<br>Completed Items | | | As of 2/1/21<br>Midpoint | | | Sources of capital: | | | | | | | | | | | | | Net cash provided by operating activities after dividends | $ | 210 | $ | 250 | $ | 230 | | | | $ | 230 | | Incremental debt | 930 | | 1,040 | | | 985 | see below | | | 735 | | | 2020 debt capital proceeds held in cash at the beginning of 2021 | 150 | | 250 | | | 200 | | | | 200 | | | Real estate dispositions and partial interest sales (refer to page 10) | 1,250 | | 1,500 | | | 1,375 | $ | 324 | | 1,375 | | | Common equity | 2,000 | | 2,400 | | | 2,200 | $ | 1,634 | (1) | 1,900 | | | Total sources of capital | $ | 4,540 | $ | 5,440 | $ | 4,990 | | | | $ | 4,440 | | Uses of capital: | | | | | | | | | | | | | Construction | $ | 1,590 | $ | 1,890 | $ | 1,740 | | | | $ | 1,740 | | Acquisitions (refer to page 9) | 2,800 | | 3,300 | | | 3,050 | $ | 2,201 | | 2,700 | | | 2021 debt capital proceeds held in cash | 150 | | 250 | | | 200 | | | | — | | | Total uses of capital | $ | 4,540 | $ | 5,440 | $ | 4,990 | | | | $ | 4,440 | | Incremental debt (included above): | | | | | | | | | | | | | Issuance of unsecured senior notes payable | $ | 1,750 | $ | 1,750 | $ | 1,750 | $ | 1,750 | (2) | $ | 900 | | Principal repayments of unsecured senior notes payable | (650) | | (650) | | | (650) | $ | (650) | (2) | — | | | Unsecured senior line of credit, commercial paper, and other | (170) | | (60) | | | (115) | | | | (165) | | | Incremental debt | $ | 930 | $ | 1,040 | $ | 985 | | | | $ | 735 |

(1)Refer to “Key capital events” on page 3 of this Earnings Press Release for additional details on our January 2021 forward equity offering and shares issued under our ATM program. As of March 31, 2021, we issued 8.8 million shares of common stock and received net proceeds of $1.4 billion in 2021. We expect to issue 1.5 million shares to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $232.6 million in 2021.

(2)Refer to “Key capital events” on page 3 of this Earnings Press Release for additional details on the issuance of our $1.75 billion unsecured senior notes payable and the refinancing of our $650.0 million unsecured senior notes payable.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 12
Earnings Call Information and About the Company
---
March 31, 2021

We will host a conference call on Tuesday, April 27, 2021, at 3:00 p.m. Eastern Time (“ET”)/noon Pacific Time (“PT”), which is open to the general public, to discuss our financial and operating results for the first quarter ended March 31, 2021. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 3:00 p.m. ET/noon PT and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the “For Investors” section. A replay of the call will be available for a limited time from 5:00 p.m. ET/2:00 p.m. PT on Tuesday, April 27, 2021. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 10151989.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the first quarter ended March 31, 2021, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2021q1.pdf.

For any questions, please contact Joel S. Marcus, executive chairman and founder; Stephen A. Richardson, co-chief executive officer; Peter M. Moglia, co-chief executive officer and co-chief investment officer; Dean A. Shigenaga, president and chief financial officer; or Paula Schwartz, managing director of Rx Communications Group, at (917) 322-2216; or Sara M. Kabakoff, vice president – communications, at (626) 578-0777.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (“REIT”), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, with a total market capitalization of $32.5 billion as of March 31, 2021, and an asset base in North America of 52.6 million square feet (“SF”). The asset base in North America includes 33.9 million RSF of operating properties and 4.0 million RSF of Class A properties undergoing construction, 7.3 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

***********

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2021 earnings per share attributable to Alexandria’s common stockholders – diluted, 2021 funds from operations per share attributable to Alexandria’s common stockholders – diluted, net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” or “will,” or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties, assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets (including the impact of the ongoing COVID-19 pandemic), our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated, we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

For additional discussion of the risks and other potential impacts posed by the outbreak of the COVID-19 pandemic and uncertainties we, our tenants, and the global and national economies face as a result, see the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K filed with the SEC on February 1, 2021.

Alexandria®, Lighthouse Design® logo, Building the Future of Life-Changing Innovation™, Labspace®, Alexandria Center®, Alexandria Technology Square®, Alexandria Technology Center®, Alexandria Innovation Center®, LaunchLabs®, and That’s What’s in Our DNA® are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names, trademarks, and logos referenced herein are the property of their respective owners.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 13
Consolidated Statements of Operations
---
March 31, 2021
(Dollars in thousands, except per share amounts) Three Months Ended
--- --- --- --- --- --- --- --- --- --- --- ---
3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Revenues:
Income from rentals $ 478,695 $ 461,335 $ 543,412 $ 435,856 $ 437,605
Other income 1,154 2,385 1,630 1,100 2,314
Total revenues 479,849 463,720 545,042 436,956 439,919
Expenses:
Rental operations 137,888 136,767 140,443 123,911 129,103
General and administrative 33,996 32,690 36,913 31,775 31,963
Interest 36,467 37,538 43,318 45,014 45,739
Depreciation and amortization 180,913 177,750 176,831 168,027 175,496
Impairment of real estate 5,129 (1) 25,177 7,680 13,218 2,003
Loss on early extinguishment of debt 67,253 7,898 52,770
Total expenses 461,646 417,820 457,955 381,945 384,304
Equity in earnings (losses) of unconsolidated real estate joint ventures 3,537 3,593 3,778 3,893 (3,116)
Investment income (loss) 1,014 255,137 3,348 184,657 (21,821)
Gain on sales of real estate 2,779 152,503 1,586
Net income 25,533 457,133 95,799 243,561 30,678
Net income attributable to noncontrolling interests (17,412) (15,649) (14,743) (13,907) (11,913)
Net income attributable to Alexandria Real Estate Equities, Inc.’s stockholders 8,121 441,484 81,056 229,654 18,765
Net income attributable to unvested restricted stock awards (2,014) (5,561) (1,730) (3,054) (1,925)
Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders $ 6,107 $ 435,923 $ 79,326 $ 226,600 $ 16,840
Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders:
Basic $ 0.04 $ 3.26 $ 0.64 $ 1.82 $ 0.14
Diluted $ 0.04 $ 3.26 $ 0.63 $ 1.82 $ 0.14
Weighted-average shares of common stock outstanding:
Basic 137,319 133,688 124,901 124,333 121,433
Diluted 137,688 133,827 125,828 124,448 121,785
Dividends declared per share of common stock $ 1.09 $ 1.09 $ 1.06 $ 1.06 $ 1.03

(1)Refer to “Funds from operations and funds from operations per share” of this Earnings Press Release for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 14
Consolidated Balance Sheets
---
March 31, 2021
(In thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
--- --- --- --- --- --- --- --- --- --- ---
Assets
Investments in real estate $ 20,253,418 $ 18,092,372 $ 17,600,648 $ 16,281,125 $ 15,832,182
Investments in unconsolidated real estate joint ventures 325,928 332,349 330,792 326,858 325,665
Cash and cash equivalents 492,184 568,532 446,255 206,860 445,255
Restricted cash 42,219 29,173 38,788 34,680 43,116
Tenant receivables 7,556 7,333 7,641 7,208 14,976
Deferred rent 751,967 722,751 719,552 688,749 663,926
Deferred leasing costs 294,328 272,673 266,440 274,483 269,458
Investments 1,641,811 1,611,114 1,330,945 1,318,465 1,123,482
Other assets 1,424,935 1,191,581 1,169,610 930,680 983,875
Total assets $ 25,234,346 $ 22,827,878 $ 21,910,671 $ 20,069,108 $ 19,701,935
Liabilities, Noncontrolling Interests, and Equity
Secured notes payable $ 229,406 $ 230,925 $ 342,363 $ 344,784 $ 347,136
Unsecured senior notes payable 8,311,512 7,232,370 7,230,819 6,738,486 6,736,999
Unsecured senior line of credit and commercial paper 99,991 249,989 440,000 221,000
Accounts payable, accrued expenses, and other liabilities 1,750,687 1,669,832 1,609,340 1,343,181 1,352,554
Dividends payable 160,779 150,982 143,040 133,681 129,981
Total liabilities 10,452,384 9,384,100 9,575,551 9,000,132 8,787,670
Commitments and contingencies
Redeemable noncontrolling interests 11,454 11,342 11,232 12,122 12,013
Alexandria Real Estate Equities, Inc.’s stockholders’ equity:
Common stock 1,457 1,367 1,333 1,246 1,243
Additional paid-in capital 12,994,748 11,730,970 10,711,119 9,443,274 9,336,949
Accumulated other comprehensive loss (5,799) (6,625) (10,638) (13,080) (15,606)
Alexandria Real Estate Equities, Inc.’s stockholders’ equity 12,990,406 11,725,712 10,701,814 9,431,440 9,322,586
Noncontrolling interests 1,780,102 1,706,724 1,622,074 1,625,414 1,579,666
Total equity 14,770,508 13,432,436 12,323,888 11,056,854 10,902,252
Total liabilities, noncontrolling interests, and equity $ 25,234,346 $ 22,827,878 $ 21,910,671 $ 20,069,108 $ 19,701,935
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 15
--- ---
Funds From Operations and Funds From Operations per Share
---
March 31, 2021
(In thousands)

The following table presents a reconciliation of net income (loss) attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria’s common stockholders – diluted, and funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below:

Three Months Ended
3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Net income attributable to Alexandria’s common stockholders $ 6,107 $ 435,923 $ 79,326 $ 226,600 $ 16,840
Depreciation and amortization of real estate assets 177,720 173,392 173,622 165,040 172,628
Noncontrolling share of depreciation and amortization from consolidated real estate JVs (15,443) (15,032) (15,256) (15,775) (15,870)
Our share of depreciation and amortization from unconsolidated real estate JVs 3,076 2,976 2,936 2,858 2,643
Gain on sales of real estate (2,779) (1) (152,503) (1,586)
Impairment of real estate – rental properties 5,129 (2) 25,177 7,680 7,644
Allocation to unvested restricted stock awards (201) (420) (1,261) (2,228) (847)
Funds from operations attributable to Alexandria’s common stockholders – diluted(3) 173,609 469,513 245,461 376,495 183,038
Unrealized losses (gains) on non-real estate investments 46,251 (233,538) 14,013 (171,652) 17,144
Realized gains on non-real estate investments (22,919) (4)
Impairment of non-real estate investments 4,702 19,780
Impairment of real estate 13,218 2,003
Loss on early extinguishment of debt 67,253 (5) 7,898 52,770
Termination fee (86,179)
Acceleration of stock compensation expense due to executive officer resignation 4,499
Allocation to unvested restricted stock awards (1,208) 2,774 179 2,251 (591)
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted $ 262,986 $ 246,647 $ 230,743 $ 225,014 $ 221,374

(1)Related to two real estate dispositions.

(2)Represents impairment charges recognized during 1Q21 to further lower the carrying amounts of three of our office properties located in our San Francisco Bay Area and Seattle markets and classified as held for sale in December 2020 to their respective estimated fair values based on the sales price negotiated for each property less costs to sell. We expect to complete these sales in 2Q21.

(3)Calculated in accordance with standards established by the Nareit Board of Governors. Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in the “Definitions and reconciliations” of our Supplemental Information for additional details.

(4)Represents the realized gain related to the acquisition of one of our privately held non-real estate investments in a biopharmaceutical company by a pharmaceutical company.

(5)Primarily related to the refinancing of our $650.0 million unsecured senior notes payable. Refer to “Key capital events” on page 3 of this Earnings Press Release for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 16
Funds From Operations and Funds From Operations per Share (continued)
---
March 31, 2021
(In thousands, except per share amounts)

The following table presents a reconciliation of net income (loss) per share attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria’s common stockholders – diluted, and funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to rounding.

Three Months Ended
3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Net income per share attributable to Alexandria’s common stockholders – diluted $ 0.04 $ 3.26 $ 0.63 $ 1.82 $ 0.14
Depreciation and amortization of real estate assets 1.20 1.21 1.28 1.22 1.31
Gain on sales of real estate (0.02) (1) (1.14) (0.01)
Impairment of real estate – rental properties 0.04 (1) 0.19 0.06 0.06
Allocation to unvested restricted stock awards (0.01) (0.01) (0.01) (0.01)
Funds from operations per share attributable to Alexandria’s common stockholders – diluted 1.26 3.51 1.95 3.03 1.50
Unrealized losses (gains) on non-real estate investments 0.34 (1.75) 0.11 (1.38) 0.14
Realized gains on non-real estate investments (0.17) (1)
Impairment of non-real estate investments 0.04 0.16
Impairment of real estate 0.11 0.02
Loss on early extinguishment of debt 0.49 (1) 0.06 0.42
Termination fee (0.69)
Acceleration of stock compensation expense due to executive officer resignation 0.04
Allocation to unvested restricted stock awards (0.01) 0.02 0.01
Funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted $ 1.91 $ 1.84 $ 1.83 $ 1.81 $ 1.82
Weighted-average shares of common stock outstanding(2) – diluted 137,688 133,827 125,828 124,448 121,785

(1)Refer to the footnotes on the prior page for additional details.

(2)Refer to “Weighted-average shares of common stock outstanding – diluted” in the “Definitions and reconciliations” of our Supplemental Information for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 17

SUPPLEMENTAL

INFORMATION

Company Profile
March 31, 2021

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office REIT, is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, with a total market capitalization of $32.5 billion as of March 31, 2021, and an asset base in North America of 52.6 million SF. The asset base in North America includes 33.9 million RSF of operating properties and 4.0 million RSF of Class A properties undergoing construction, 7.3 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

Tenant base

Alexandria is known for our high-quality and diverse tenant base, with 55% of our annual rental revenue generated from tenants that are investment-grade rated or publicly traded large cap companies. The quality, diversity, breadth, and depth of our significant relationships with our tenants provide Alexandria with high-quality and stable cash flows. Alexandria’s underwriting team and long-term industry relationships positively distinguish us from all other publicly traded REITs and real estate companies.

Executive and senior management team

Alexandria’s executive and senior management team has unique experience and expertise in creating, owning, and operating highly dynamic and collaborative campuses in key urban life science, agtech, and technology cluster locations that inspire innovation. From the development of high-quality, sustainable real estate, to the ongoing cultivation of collaborative environments with unique amenities and events, the Alexandria team has a first-in-class reputation of excellence in our niche. Alexandria’s highly experienced management team also includes regional market directors with leading reputations and longstanding relationships within the life science, agtech, and technology communities in their respective innovation clusters. We believe that our expertise, experience, reputation, and key relationships in the real estate, life science, agtech, and technology sectors provide Alexandria significant competitive advantages in attracting new business opportunities.

Alexandria’s executive and senior management team consists of 52 individuals, averaging 24 years of real estate experience, including 11 years with Alexandria. Our executive management team alone averages 17 years of experience with Alexandria.

EXECUTIVE MANAGEMENT TEAM
Joel S. Marcus Stephen A. Richardson
Executive Chairman & Founder Co-Chief Executive Officer
Dean A. Shigenaga Peter M. Moglia
President & Chief Financial Officer Co-Chief Executive Officer & <br>Co-Chief Investment Officer
Daniel J. Ryan Lawrence J. Diamond
Co-Chief Investment Officer & Regional Market Director – San Diego Co-Chief Operating Officer & Regional Market Director – Maryland
Vincent R. Ciruzzi John H. Cunningham
Chief Development Officer Executive Vice President – Regional Market Director – New York City
Hunter L. Kass Jackie B. Clem
Executive Vice President – Regional Market Director – Greater Boston General Counsel & Secretary
Joseph Hakman Terezia C. Nemeth
Co-Chief Operating Officer & <br>Chief Strategic Transactions Officer Executive Vice President – Regional Market Director – San Francisco <br>Bay Area
Marc E. Binda Andres R. Gavinet
Executive Vice President – <br>Finance & Treasurer Chief Accounting Officer
Gary D. Dean
Executive Vice President – <br>Real Estate Legal Affairs
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 19
--- ---
Investor Information
---
March 31, 2021 Corporate Headquarters New York Stock Exchange Trading Symbol Information Requests
--- --- --- ---
26 North Euclid Avenue Common stock: ARE Phone: (626) 578-0777
Pasadena, California 91101 Email: corporateinformation@are.com
Web: www.are.com Equity Research Coverage
--- Alexandria is currently covered by the following research analysts. This list may be incomplete and is subject to change as firms initiate or discontinue coverage of our company. Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, estimates, or forecasts of Alexandria or our management. Alexandria does not by our reference or distribution of the information below imply our endorsement of or concurrence with any opinions, estimates, or forecasts of these analysts. Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports. Several of these firms may, from time to time, own our stock and/or hold other long or short positions in our stock and may provide compensated services to us.
---
Bank of America Merrill Lynch Citigroup Global Markets Inc. JMP Securities RBC Capital Markets
--- --- --- ---
Jamie Feldman / Elvis Rodriguez Michael Bilerman / Emmanuel Korchman Aaron Hecht / Matthew Hurwit Michael Carroll / Jason Idoine
(646) 855-5808 / (646) 855-1589 (212) 816-1383 / (212) 816-1382 (415) 835-3963 / (415) 835-3964 (440) 715-2649 / (440) 715-2651
Berenberg Capital Markets Evercore ISI J.P. Morgan Securities LLC Robert W. Baird & Co. Incorporated
Connor Siversky / Nate Crossett Sheila McGrath / Wendy Ma Anthony Paolone / Ray Zhong David Rodgers / Nicholas Thillman
(646) 949-9037 / (646) 949-9030 (212) 497-0882 / (212) 497-0870 (212) 622-6682 / (212) 622-5411 (216) 737-7341 / (414) 298-5053
BTIG, LLC Green Street Mizuho Securities USA Inc. SMBC Nikko Securities America, Inc.
Tom Catherwood / James Sullivan Daniel Ismail / Dylan Burzinski Omotayo Okusanya / Venkat Kommineni Richard Anderson / Jay Kornreich
(212) 738-6140 / (212) 738-6139 (949) 640-8780 / (949) 640-8780 (646) 949-9672 / (646) 949-9754 (646) 521-2351 / (646) 424-3202
CFRA
Kenneth Leon
(646) 517-2552
Fixed Income Coverage Rating Agencies
Barclays Capital Inc. J.P. Morgan Securities LLC Moody’s Investors Service S&P Global Ratings
Srinjoy Banerjee / Devon Zhou Mark Streeter / Ian Snyder (212) 553-0376 Fernanda Hernandez / Michael Souers
(212) 526-3521 / (212) 526-6961 (212) 834-5086 / (212) 834-3798 (212) 438-1347 / (212) 438-2508 Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 20
--- ---
Financial and Asset Base Highlights
---
March 31, 2021
(Dollars in thousands, except per share amounts)
Three Months Ended (unless stated otherwise)
--- --- --- --- --- ---
3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Selected financial data from consolidated financial statements and related information
Rental revenues
Tenant recoveries
General and administrative expenses
General and administrative expenses as a percentage of net operating income –<br><br>trailing 12 months 9.8% 9.8% 9.9% 10.3% 10.2%
Operating margin 71% 71% 74% 72% 71%
Adjusted EBITDA margin 69% 69% 67% 69% 68%
Adjusted EBITDA – quarter annualized
Adjusted EBITDA – trailing 12 months
Net debt at end of period
Net debt and preferred stock to Adjusted EBITDA – quarter annualized 5.8x 5.3x 5.8x 5.8x 5.5x
Net debt and preferred stock to Adjusted EBITDA – trailing 12 months 6.1x 5.5x 6.0x 6.2x 6.0x
Fixed-charge coverage ratio – quarter annualized 4.7x 4.6x 4.3x 4.2x 4.5x
Fixed-charge coverage ratio – trailing 12 months 4.4x 4.4x 4.3x 4.2x 4.2x
Unencumbered net operating income as a percentage of total net operating income 97% 97% 96% 95% 95%
Closing stock price at end of period
Common shares outstanding (in thousands) at end of period 145,656 136,690 133,312 124,559 124,326
Total equity capitalization at end of period
Total market capitalization at end of period
Dividend per share – quarter/annualized 1.09/4.36 1.09/4.36 1.06/4.24 1.06/4.24 1.03/4.12
Dividend payout ratio for the quarter 60% 60% 61% 59% 58%
Dividend yield – annualized 2.7% 2.4% 2.7% 2.6% 3.0%
Amounts related to operating leases:
Operating lease liabilities
Rent expense
Capitalized interest
Weighted-average interest rate for capitalization of interest during the period 3.44% 3.66% 3.64% 4.03% 3.80%

All values are in US Dollars.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 21 | | --- | --- || Financial and Asset Base Highlights (continued) | | --- | | March 31, 2021 | | (Dollars in thousands, except annual rental revenue per occupied RSF amounts) || | Three Months Ended (unless stated otherwise) | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 3/31/21 | | | 12/31/20 | | 9/30/20 | | 6/30/20 | | 3/31/20 | | | Amounts included in funds from operations and non-revenue-enhancing capital expenditures | | | | | | | | | | | | | Straight-line rent revenue | $ | 27,382 | | $ | 23,890 | $ | 28,822 | $ | 23,367 | $ | 20,597 | | Amortization of acquired below-market leases | $ | 12,112 | | $ | 13,514 | $ | 13,979 | $ | 13,787 | $ | 15,964 | | Straight-line rent expense on ground leases | $ | 290 | | $ | 348 | $ | 229 | $ | 167 | $ | 171 | | Stock compensation expense | $ | 12,446 | | $ | 11,394 | $ | 12,994 | $ | 9,185 | $ | 9,929 | | Amortization of loan fees | $ | 2,817 | | $ | 2,905 | $ | 2,605 | $ | 2,737 | $ | 2,247 | | Amortization of debt premiums | $ | 576 | | $ | 869 | $ | 910 | $ | 888 | $ | 888 | | Non-revenue-enhancing capital expenditures: | | | | | | | | | | | | | Building improvements | $ | 3,760 | | $ | 3,466 | $ | 3,358 | $ | 3,107 | $ | 3,198 | | Tenant improvements and leasing commissions | $ | 16,035 | | $ | 31,235 | $ | 34,036 | $ | 11,500 | $ | 12,923 | | Operating statistics and related information (at end of period) | | | | | | | | | | | | | Number of properties – North America | 360 | | | 338 | | 326 | | 304 | | 302 | | | RSF – North America (including development and redevelopment projects under construction) | 37,916,882 | | | 35,163,572 | | 34,071,653 | | 31,141,758 | | 30,924,356 | | | Total square feet – North America | 52,591,039 | | | 49,712,701 | | 47,389,023 | | 43,023,989 | | 41,514,374 | | | Annual rental revenue per occupied RSF – North America | $ | 49.58 | | $ | 49.08 | $ | 49.55 | $ | 51.30 | $ | 51.18 | | Occupancy of operating properties – North America | 94.5% | | (1) | 94.6% | | 94.9% | | 94.8% | | 95.1% | | | Occupancy of operating and redevelopment properties – North America | 89.2% | | | 90.0% | | 91.3% | | 92.3% | | 92.9% | | | Weighted-average remaining lease term (in years) | 7.6 | | | 7.6 | | 7.7 | | 7.8 | | 7.8 | | | Total leasing activity – RSF | 1,677,659 | | | 1,369,599 | | 1,208,382 | | 1,077,510 | | 703,355 | | | Lease renewals and re-leasing of space – change in average new rental rates over expiring rates: | | | | | | | | | | | | | Rental rate increases | 36.2% | | | 29.8% | | 39.9% | | 37.2% | | 46.3% | | | Rental rate increases (cash basis) | 17.4% | | | 10.7% | | 30.9% | | 15.0% | | 22.3% | | | RSF (included in total leasing activity above) | 521,825 | | | 699,916 | | 605,765 | | 699,130 | | 557,367 | | | Same property – percentage change over comparable quarter from prior year: | | | | | | | | | | | | | Net operating income increase | 4.4% | | | 2.7% | | 2.9% | | 0.6% | | 2.4% | | | Net operating income increase (cash basis) | 6.1% | | | 5.0% | | 4.9% | | 2.5% | | 6.1% | |

(1)Refer to “Occupancy” in this Supplemental Information for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 22
High-Quality, Diverse, and Innovative Tenants
---
March 31, 2021

Long-Duration Cash Flows From High-Quality, Diverse, and

Innovative Tenants

Investment-Grade or<br>Publicly Traded Large Cap Tenants Tenant Mix
55%
of ARE’s Annual Rental Revenue(1)
Long-Duration Lease Terms
7.6 Years
Weighted-Average Remaining Term(2)
Percentage of ARE’s Annual Rental Revenue(1)

(1)Represents annual rental revenue in effect as of March 31, 2021.

(2)Based on aggregate annual rental revenue in effect as of March 31, 2021. Refer to “Annual rental revenue” in the “Definitions and reconciliations” of this Supplemental Information for additional details about our methodology on annual rental revenue from unconsolidated real estate joint ventures.

(3)Represents annual rental revenue currently generated from office space that is targeted for a future change in use. The weighted-average remaining term of these leases is 3.0 years.

(4)Represents annual rental revenue from publicly traded tech tenants with an average daily market capitalization greater than $200 billion for the twelve months ended March 31, 2021.

(5)Our other tenants, aggregating 5.0% of our annual rental revenue, comprise 4.2% of annual rental revenue from technology, professional services, finance, telecommunications, and construction/real estate companies and only 0.8% from retail-related tenants.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 23
Class A Properties in AAA Locations
---
March 31, 2021

High-Quality Cash Flows From High Quality Tenants and

Class A Properties in AAA Locations

Industry-Leading<br>Tenant Roster AAA Locations
88%
of ARE’s Top 20
Annual Rental Revenue(1)
From Investment-Grade
or Publicly Traded Large Cap Tenants
Percentage of ARE’s Annual Rental Revenue(1)

(1)Represents annual rental revenue in effect as of March 31, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 24
Occupancy
---
March 31, 2021 Solid Historical Occupancy(1) Occupancy Across Key Locations(2)
--- ---
96%
Over 10 Years

(1)Represents average occupancy of operating properties in North America as of each December 31 for the last 10 years and as of March 31, 2021.

(2)As of March 31, 2021.

(3)Includes 1.2 million RSF, or 3.5%, of vacancy at recently acquired properties in our North America markets (noted below), representing lease-up opportunities that will contribute to growth in cash flows. Approximately 26% of the vacant 1.2 million RSF is currently leased, with occupancy expected primarily over the next two quarters. Excluding these acquired vacancies, occupancy of operating properties in North America was 98.0% as of March 31, 2021. The estimated cost basis associated with these spaces was approximately $451.3 million as of March 31, 2021.

As of March 31, 2021
Vacant Occupancy Impact
Property Market/Submarket RSF Region Consolidated
Alexandria Center® for Life Science – Durham Research Triangle/Research Triangle 233,362 8.3 % 0.7 %
601, 611, and 651 Gateway Boulevard San Francisco Bay Area/South San Francisco 254,582 3.4 % 0.8
SD Tech by Alexandria San Diego/Sorrento Mesa 83,171 1.3 % 0.2
Other acquisitions Various 518,830 N/A 1.5
1,089,945 3.2
1Q21 acquisitions:
Alexandria Center® for Life Science – Fenway Greater Boston/Fenway 98,174 1.0 % 0.3
1,188,119 3.5 % Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 25
--- ---
Key Operating Metrics
---
March 31, 2021 Historical Same Property<br>Net Operating Income Favorable Lease Structure(1)
--- --- --- --- ---
q121sampropav31a.jpg Strategic Lease Structure by Owner and Operator of Collaborative <br>Life Science, Agtech, and Technology Campuses
Increasing cash flows
Percentage of leases containing<br><br>annual rent escalations 95%
Stable cash flows
Percentage of triple<br><br>net leases 94%
Lower capex burden
Percentage of leases providing for the<br><br>recapture of capital expenditures 93%
Historical Rental Rates: <br>Renewed/Re-Leased Space Margins(2)
Operating Adjusted EBITDA
71% 69%

(1)Percentages calculated based on RSF as of March 31, 2021.

(2)Represents percentages for the three months ended March 31, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 26
Same Property Performance
---
March 31, 2021
(Dollars in thousands) Same Property Financial Data Three Months Ended March 31, 2021 Same Property Statistical Data Three Months Ended March 31, 2021
--- --- --- --- --- ---
Percentage change over comparable period from prior year: Number of same properties 250
Net operating income increase 4.4% Rentable square feet 23,716,975
Net operating income increase (cash basis) 6.1% Occupancy – current-period average 96.3%
Operating margin 73% Occupancy – same-period prior-year average 96.4%
Three Months Ended March 31,
--- --- --- --- --- --- --- ---
2021 2020 Change % Change
Income from rentals:
Same properties $ 302,036 $ 294,616 2.5 %
Non-same properties 68,197 43,326 24,871 57.4
Rental revenues 370,233 337,942 32,291 9.6
Same properties 96,638 92,280 4,358 4.7
Non-same properties 11,824 7,383 4,441 60.2
Tenant recoveries 108,462 99,663 8,799 8.8
Income from rentals 478,695 437,605 41,090 9.4
Same properties 101 100 1 1.0
Non-same properties 1,053 2,214 (1,161) (52.4)
Other income 1,154 2,314 (1,160) (50.1)
Same properties 398,775 386,996 11,779 3.0
Non-same properties 81,074 52,923 28,151 53.2
Total revenues 479,849 439,919 39,930 9.1
Same properties 108,395 108,947 (552) (0.5)
Non-same properties 29,493 20,156 9,337 46.3
Rental operations 137,888 129,103 8,785 6.8
Same properties 290,380 278,049 12,331 4.4
Non-same properties 51,581 32,767 18,814 57.4
Net operating income $ 341,961 $ 310,816 10.0 %
Net operating income – same properties $ 290,380 $ 278,049 4.4 %
Straight-line rent revenue (17,582) (19,417) 1,835 (9.5)
Amortization of acquired below-market leases (3,466) (4,778) 1,312 (27.5)
Net operating income – same properties (cash basis) $ 269,332 $ 253,854 6.1 %

All values are in US Dollars.

Refer to “Same property comparisons” in the “Definitions and reconciliations” of this Supplemental Information for a reconciliation of same properties to total properties. “Definitions and reconciliations” also contains definitions of “Tenant recoveries” and “Net operating income” and their respective reconciliations from the most directly comparable financial measures presented in accordance with GAAP.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 27
Leasing Activity
---
March 31, 2021
(Dollars per RSF)
Three Months Ended Year Ended
--- --- --- --- --- --- --- ---
March 31, 2021 December 31, 2020
Including <br>Straight-Line Rent Cash Basis Including <br>Straight-Line Rent
Leasing activity:
Renewed/re-leased space(1)
Rental rate changes 36.2% 17.4% 37.6%
New rates 57.61 54.85 49.51
Expiring rates 42.31 46.74 35.99
RSF 521,825 2,556,833
Tenant improvements/leasing commissions 30.73 35.08
Weighted-average lease term 6.9 years 6.0 years
Developed/redeveloped/previously vacant space leased
New rates 49.14 45.67 56.67
RSF 1,155,834 1,802,013
Tenant improvements/leasing commissions 37.17 28.17
Weighted-average lease term 10.7 years 9.0 years
Leasing activity summary (totals):
New rates 51.78 48.53 52.47
RSF 1,677,659 4,358,846
Tenant improvements/leasing commissions 35.17 32.22
Weighted-average lease term 9.5 years 7.3 years
Lease expirations(1)
Expiring rates 40.70 43.84 36.03
RSF 747,275 3,560,188

All values are in US Dollars.

Leasing activity includes 100% of results for each property in which we have an investment in North America.

(1)Excludes month-to-month leases aggregating 82,972 RSF and 96,383 RSF as of March 31, 2021, and December 31, 2020, respectively.

(2)During the three months ended March 31, 2021, we granted tenant concessions/free rent averaging 3.5 months with respect to the 1,677,659 RSF leased. Approximately 41% of the leases executed during the three months ended March 31, 2021, did not include concessions for free rent.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 28
Contractual Lease Expirations
---
March 31, 2021 Year RSF Percentage of<br>Occupied RSF Annual Rental Revenue (per RSF)(1) Percentage of Total<br>Annual Rental Revenue
--- --- --- --- --- --- --- --- --- --- --- --- --- ---
2021 (2) 1,244,636 3.9 % $ 43.05 3.4 %
2022 2,601,783 8.2 % $ 45.96 7.6 %
2023 3,587,104 11.3 % $ 41.05 9.4 %
2024 2,472,214 7.8 % $ 45.47 7.2 %
2025 2,581,288 8.1 % $ 47.25 7.8 %
2026 2,036,500 6.4 % $ 46.54 6.1 %
2027 2,207,171 6.9 % $ 50.50 7.1 %
2028 2,540,712 8.0 % $ 49.56 8.0 %
2029 2,006,321 6.3 % $ 54.14 6.9 %
2030 2,288,097 7.2 % $ 53.70 7.9 %
Thereafter 8,310,754 25.9 % $ 53.73 28.6 %
Market 2021 Contractual Lease Expirations (in RSF) Annual Rental Revenue<br><br>(per RSF)(1) 2022 Contractual Lease Expirations (in RSF) Annual Rental Revenue<br><br>(per RSF)(1)
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Leased Negotiating/<br>Anticipating Targeted for<br><br>Development/<br><br>Redevelopment(3) Remaining<br><br>Expiring<br><br>Leases(4) Total(2) Leased Negotiating/<br>Anticipating Targeted for<br><br>Development/<br><br>Redevelopment(3) Remaining<br><br>Expiring Leases(5) Total
Greater Boston 17,975 101,103 202,428 115,392 436,898 $ 45.21 44,767 8,998 514,925 (6) 568,690 $ 58.57
San Francisco Bay Area 202,268 36,564 9,738 144,640 393,210 49.58 7,180 490,127 302,531 799,838 53.01
New York City 2,007 2,007 N/A 30,408 14,891 2,979 48,278 N/A
San Diego 6,493 5,749 83,697 101,251 197,190 32.74 114,656 24,523 231,585 157,604 528,368 37.83
Seattle 15,184 58,058 73,242 29.66 50,618 51,255 146,061 247,934 31.99
Maryland 11,438 11,438 31.75 29,283 49,439 78,722 26.95
Research Triangle 16,942 41,399 58,341 32.12 251,706 251,706 21.05
Canada 13,672 13,672 25.09 28,664 28,664 22.19
Non-cluster/other markets 58,638 58,638 44.70 49,583 49,583 55.84
Total 243,678 158,600 295,863 546,495 1,244,636 $ 43.05 189,831 135,493 772,967 1,503,492 2,601,783 $ 45.96
Percentage of expiring leases 20 % 13 % 24 % 43 % 100 % 7 % 5 % 30 % 58 % 100 %

(1)Represents amounts in effect as of March 31, 2021.

(2)Excludes month-to-month leases aggregating 82,972 RSF as of March 31, 2021.

(3)Represents RSF targeted for development or redevelopment upon expiration of existing in-place leases, primarily related to recently acquired properties. Refer to “Investments in real estate” in the “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.

(4)The largest remaining contractual lease expiration is a 55,183 RSF lease in our Mission Bay submarket.

(5)The largest remaining contractual lease expiration includes a Class A office/laboratory building for 113,555 RSF in our Cambridge/Inner Suburbs submarket and one lease for 62,490 RSF in our Research Triangle submarket.

(6)72% of the remaining expiring leases in Greater Boston are located in our Cambridge/Inner Suburbs submarket.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 29
Top 20 Tenants
---
March 31, 2021
(Dollars in thousands, except average market cap amounts)

88% of Top 20 Annual Rental Revenue From Investment-Grade

or Publicly Traded Large Cap Tenants(1)

Tenant Remaining Lease Term(1) (in years) Aggregate <br>RSF Annual Rental Revenue(1) Percentage of Aggregate Annual Rental Revenue(1) Investment-Grade <br>Credit Ratings Average Market Cap(1)<br><br>(in billions)
Moody’s S&P
1 Bristol-Myers Squibb Company 7.4 916,234 $ 52,853 3.4 % A2 A+ $ 137.5
2 Takeda Pharmaceutical Company Ltd. 8.4 606,249 39,342 2.6 Baa2 BBB+ $ 56.5
3 Facebook, Inc. 10.8 903,786 38,899 2.5 $ 719.2
4 Illumina, Inc. 9.4 891,495 36,058 2.3 Baa3 BBB $ 52.3
5 Eli Lilly and Company 8.0 555,335 35,807 2.3 A2 A+ $ 156.0
6 Sanofi 7.2 494,693 33,868 2.2 A1 AA $ 124.2
7 Moderna, Inc. 11.2 615,458 32,147 2.1 $ 36.3
8 Novartis AG 7.4 423,914 30,128 2.0 A1 AA- $ 216.6
9 Uber Technologies, Inc. 61.7 (2) 1,009,188 27,379 1.8 $ 73.8
10 Roche 2.4 (3) 612,242 25,768 1.7 Aa3 AA $ 298.4
11 bluebird bio, Inc. 6.2 312,805 23,142 1.5 $ 3.3
12 Maxar Technologies 4.2 (4) 478,000 21,577 1.4 $ 1.7
13 Massachusetts Institute of Technology 7.7 257,626 21,145 1.4 Aaa AAA $
14 The Children's Hospital Corporation 17.6 269,816 20,066 1.3 Aa2 AA $
15 Jazz Pharmaceuticals, Inc. 9.4 198,041 20,003 1.3 $ 7.6
16 New York University 10.5 204,691 19,531 1.3 Aa2 AA- $
17 Merck & Co., Inc. 13.2 311,015 19,392 1.3 A1 AA- $ 201.4
18 Pfizer Inc. 3.9 416,979 17,762 1.2 A2 A+ $ 202.8
19 United States Government 6.6 296,765 16,933 1.1 Aaa AA+ $
20 Amgen Inc. 3.0 407,369 16,838 1.1 Baa1 A- $ 138.0
Total/weighted-average 10.9 (2) 10,181,701 $ 548,638 35.8 %

(1)Based on aggregate annual rental revenue in effect as of March 31, 2021. Refer to “Annual rental revenue” and “Investment-grade or publicly traded large cap tenants” in the “Definitions and reconciliations” of this Supplemental Information for additional details about our methodology on annual rental revenue from unconsolidated real estate joint ventures and average daily market capitalization.

(2)Includes (i) ground leases for land at 1455 and 1515 Third Street (two buildings aggregating 422,980 RSF) and (ii) leases at 1655 and 1725 Third Street (two buildings aggregating 586,208 RSF) owned by our unconsolidated real estate joint venture in which we have an ownership interest of 10%. Annual rental revenue is presented using 100% of the annual rental revenue of our consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Refer to footnote 1 for additional details. Excluding the ground lease, the weighted-average remaining lease term for our top 20 tenants was 8.2 years as of March 31, 2021.

(3)Includes 197,787 RSF expiring in 2022 at our recently acquired property at 651 Gateway Boulevard in our South San Francisco submarket. Upon expiration of the lease, 651 Gateway Boulevard will be redeveloped into a Class A office/laboratory building. Excluding this 197,787 RSF, the weighted-average remaining term of space occupied by Roche is 2.8 years.

(4)Represents remaining lease term at two properties with future redevelopment and development opportunities. The leases with this tenant were in place when we acquired the properties in 4Q19.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 30
Summary of Properties and Occupancy
---
March 31, 2021
(Dollars in thousands, except per RSF amounts)

Summary of properties

Market RSF Number of Properties Annual Rental Revenue
Operating Development Redevelopment Total % of Total Total % of Total Per RSF
Greater Boston 9,393,117 510,116 490,545 10,393,778 27 % 75 $ 563,356 37 % $ 62.32
San Francisco Bay Area 7,582,096 645,158 92,147 8,319,401 22 60 374,050 24 59.25
New York City 1,145,296 122,382 1,267,678 3 5 82,226 5 72.24
San Diego 6,322,521 322,884 208,690 6,854,095 19 81 236,430 16 40.10
Seattle 2,628,577 213,976 2,842,553 7 40 105,819 7 41.57
Maryland 2,998,406 84,264 249,970 3,332,640 9 45 92,085 6 31.36
Research Triangle 2,810,670 410,000 652,381 3,873,051 10 35 62,527 4 24.50
Canada 256,967 256,967 1 3 5,151 24.55
Non-cluster/other markets 550,870 550,870 1 12 11,478 1 39.65
Properties held for sale 225,849 225,849 1 4 6,231 N/A
North America 33,914,369 1,972,422 2,030,091 37,916,882 100 % 360 $ 1,539,353 100 % $ 49.58
4,002,513

Summary of occupancy

Operating Properties Operating and Redevelopment Properties
Market 3/31/21 12/31/20 3/31/20 3/31/21 12/31/20 3/31/20
Greater Boston 96.2 % (1) 98.1 % 98.9 % 91.5 % 94.8 % 97.0 %
San Francisco Bay Area 95.4 (1) 95.8 94.7 94.3 94.7 90.6
New York City 99.4 97.3 99.2 89.8 87.8 88.1
San Diego 93.3 (1) 93.5 90.9 90.3 92.4 90.9
Seattle 96.8 96.0 97.8 89.6 85.5 97.8
Maryland 97.9 96.1 95.9 90.4 90.6 94.6
Research Triangle 90.8 (1) 89.6 96.5 73.7 72.7 96.5
Subtotal 95.3 95.5 95.6 89.9 90.7 93.3
Canada 81.6 81.8 93.6 81.6 81.8 93.6
Non-cluster/other markets 52.6 52.7 65.2 52.6 52.7 65.2
North America 94.5 % (1) 94.6 % 95.1 % 89.2 % 90.0 % 92.9 %

(1)Refer to “Occupancy” of this Supplemental Information for additional details on vacancy at acquired properties.

Refer to “Definitions and reconciliations” of this Supplemental Information for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 31
Property Listing
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
Greater Boston
Cambridge/Inner Suburbs
Alexandria Center® at Kendall Square 2,365,487 2,365,487 10 $ 168,750 98.9 % 98.9 %
50, 60, 75/125(1), 100, and 225(1) Binney Street, 161 and 215 First Street, 150 Second Street, 300 Third Street, and 11 Hurley Street
Alexandria Technology Square® 1,181,635 1,181,635 7 101,814 97.9 97.9
100, 200, 300, 400, 500, 600, and 700 Technology Square
The Arsenal on the Charles 475,743 360,545 836,288 11 18,195 89.3 50.8
311, 321, and 343 Arsenal Street, 300 and 400 North Beacon Street,<br> 1, 2, and 3 Kingsbury Avenue, and 100, 200, and 400 Talcott Avenue
Alexandria Center® at One Kendall Square 814,779 814,779 10 70,167 98.6 98.6
One Kendall Square – Buildings 100, 200, 300, 400, 500, 600/700, 1400, 1800, 2000, and 399 Binney Street
480 and 500 Arsenal Street 234,260 234,260 2 10,955 93.1 93.1
640 Memorial Drive 225,504 225,504 1 13,860 100.0 100.0
780 and 790 Memorial Drive 99,658 99,658 2 8,292 100.0 100.0
167 Sidney Street and 99 Erie Street 54,549 54,549 2 4,025 100.0 100.0
79/96 13th Street (Charlestown Navy Yard) 25,309 25,309 1 620 100.0 100.0
Cambridge/Inner Suburbs 5,476,924 360,545 5,837,469 46 396,678 97.6 91.6
Fenway
Alexandria Center® for Life Science – Fenway 973,145 510,116 1,483,261 2 56,780 90.0 90.0
401 Park Drive and 201 Brookline Avenue(1)
Seaport Innovation District
380 and 420 E Street 195,506 195,506 2 3,522 100.0 100.0
5 Necco Street 87,163 87,163 1 4,672 86.6 86.6
Seaport Innovation District 282,669 282,669 3 8,194 95.9 95.9
Route 128
Reservoir Woods 515,273 515,273 3 22,004 100.0 100.0
40, 50, and 60 Sylvan Road
275 Grove Street 509,702 509,702 1 22,516 87.4 87.4
One Upland Road and 100 Tech Drive 443,513 443,513 2 18,008 100.0 100.0
Alexandria Park at 128 343,882 343,882 8 12,544 100.0 100.0
3 and 6/8 Preston Court, 29, 35, and 44 Hartwell Avenue, 35 and 45/47 Wiggins Avenue, and 60 Westview Street
225, 266, and 275 Second Avenue 317,617 317,617 3 12,343 84.8 84.8
19 Presidential Way 144,892 144,892 1 4,808 99.8 99.8
840 Winter Street 30,009 130,000 160,009 1 1,315 100.0 18.8
100 Beaver Street 82,330 82,330 1 4,605 100.0 100.0
285 Bear Hill Road 26,270 26,270 1 1,167 100.0 100.0
Route 128 2,413,488 130,000 2,543,488 21 $ 99,310 95.3 % 90.4 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 32
--- --- Property Listing (continued)
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
Greater Boston (continued)
Route 495
111 and 130 Forbes Boulevard 155,846 155,846 2 $ 1,745 100.0 % 100.0 %
20 Walkup Drive 91,045 91,045 1 649 100.0 100.0
Route 495 246,891 246,891 3 2,394 100.0 100.0
Greater Boston 9,393,117 510,116 490,545 10,393,778 75 563,356 96.2 91.5
San Francisco Bay Area
Mission Bay
Alexandria Center® for Science and Technology – Mission Bay 1,990,262 1,990,262 9 91,785 99.9 99.9
1455, 1515, 1655(1), and 1725(1) Third Street, 409 and 499 Illinois Street(1), 1500(1) and 1700 Owens Street, and 455 Mission Bay Boulevard South
Mission Bay 1,990,262 1,990,262 9 91,785 99.9 99.9
South San Francisco
Alexandria Technology Center® – Gateway 1,413,067 1,413,067 11 56,371 78.6 78.6
600, 601(1), 611(1), 630, 650, 651(1), 681(1), 685(1), 701(1), 901, and 951 Gateway Boulevard
213, 249, 259, 269, and 279 East Grand Avenue 919,704 919,704 5 48,764 100.0 100.0
201 Haskins Way 315,000 315,000 1 N/A N/A
400 and 450 East Jamie Court 163,035 163,035 2 10,211 100.0 100.0
500 Forbes Boulevard(1) 155,685 155,685 1 6,619 100.0 100.0
7000 Shoreline Court 139,709 139,709 1 8,631 100.0 100.0
341 and 343 Oyster Point Boulevard 108,208 108,208 2 6,443 100.0 100.0
849/863 Mitten Road/866 Malcolm Road 103,857 103,857 1 4,561 100.0 100.0
South San Francisco 3,003,265 315,000 3,318,265 24 141,600 89.9 89.9
Greater Stanford
Menlo Gateway(1) 772,983 772,983 3 29,790 100.0 100.0
100 Independence Drive and 125 and 135 Constitution Drive
Alexandria Center® for Life Science – San Carlos 315,758 330,158 645,916 4 18,076 100.0 100.0
825, 835, and 960 Industrial Road and 1075 Commercial Street
3825 and 3875 Fabian Way 478,000 478,000 2 21,577 100.0 100.0
Alexandria Stanford Life Science District 289,685 92,147 381,832 4 23,888 100.0 75.9
3160, 3165, 3170, and 3181 Porter Drive
Alexandria PARC 197,498 197,498 4 9,291 78.1 78.1
2100, 2200, 2300, and 2400 Geng Road
3330, 3412, 3450, and 3460 Hillview Avenue 183,267 183,267 4 15,180 100.0 100.0
2425 Garcia Avenue/2400/2450 Bayshore Parkway 99,208 99,208 1 4,257 100.0 100.0
Shoreway Science Center 82,462 82,462 2 4,952 100.0 100.0
75 and 125 Shoreway Road
1450 Page Mill Road 77,634 77,634 1 8,009 100.0 100.0
3350 West Bayshore Road 60,000 60,000 1 3,780 99.5 99.5
2625/2627/2631 Hanover Street 32,074 32,074 1 1,865 100.0 100.0
Greater Stanford 2,588,569 330,158 92,147 3,010,874 27 140,665 98.3 94.9
San Francisco Bay Area 7,582,096 645,158 92,147 8,319,401 60 $ 374,050 95.4 % 94.3 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 33
--- --- Property Listing (continued)
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
New York City
New York City
Alexandria Center® for Life Science – New York City 740,972 740,972 3 $ 66,054 99.0 % 99.0 %
430 and 450 East 29th Street
219 East 42nd Street 349,947 349,947 1 14,006 100.0 100.0
Alexandria Center® for Life Science – Long Island City 54,377 122,382 176,759 1 2,166 100.0 30.8
30-02 48th Avenue
New York City 1,145,296 122,382 1,267,678 5 82,226 99.4 89.8
San Diego
Torrey Pines
ARE Spectrum 336,461 146,456 482,917 4 18,072 100.0 100.0
3115 and 3215 Merryfield Row and 3013 and 3033 Science Park Road
ARE Torrey Ridge 294,326 294,326 3 12,296 84.6 84.6
10578, 10618, and 10628 Science Center Drive
ARE Sunrise 236,635 236,635 3 5,056 68.5 68.5
10931/10933 and 10975 North Torrey Pines Road, 3010 Science Park Road, and 10996 Torreyana Road
ARE Nautilus 220,651 220,651 4 10,924 100.0 100.0
3530 and 3550 John Hopkins Court and 3535 and 3565 General Atomics Court
11119, 11255, and 11355 North Torrey Pines Road 211,641 211,641 3 8,738 100.0 100.0
3545 Cray Court 118,225 118,225 1 3,636 46.1 46.1
Torrey Pines 1,417,939 146,456 1,564,395 18 58,722 87.1 87.1
University Town Center
Alexandria Point(1) 1,435,916 1,435,916 8 62,467 99.1 99.1
9880(2), 10210, 10260, 10290, and 10300 Campus Point Drive and 4161, 4224, and 4242 Campus Point Court
5200 Illumina Way(1) 792,687 792,687 6 29,977 100.0 100.0
University District 490,429 490,429 7 18,883 100.0 100.0
9393 and 9625(1) Towne Centre Drive, 4755, 4757, and 4767 Nexus Center Drive, and 4555 and 4796 Executive Drive
University Town Center 2,719,032 2,719,032 21 $ 111,327 99.5 % 99.5 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.<br><br>(2)We own 100% of this property. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 34
--- --- Property Listing (continued)
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
San Diego (continued)
Sorrento Mesa
SD Tech by Alexandria(1) 779,989 176,428 79,945 1,036,362 14 $ 24,065 86.1 % 78.1 %
9605, 9645, 9675, 9685, 9725, 9735, 9808, 9855, and 9868 Scranton Road, 5505 Morehouse Drive(2), and 10055, 10065, 10121(2), and 10151(2) Barnes Canyon Road
6420 and 6450 Sequence Drive 318,200 318,200 2 7,774 81.0 81.0
Summers Ridge Science Park 316,531 316,531 4 11,077 100.0 100.0
9965, 9975, 9985, and 9995 Summers Ridge Road
ARE Portola 101,857 101,857 3 3,603 100.0 100.0
6175, 6225, and 6275 Nancy Ridge Drive
5810/5820 Nancy Ridge Drive 82,272 82,272 1 1,031 41.4 41.4
7330 Carroll Road 66,244 66,244 1 2,431 100.0 100.0
9877 Waples Street 63,774 63,774 1 2,374 100.0 100.0
5871 Oberlin Drive 33,842 33,842 1 1,710 100.0 100.0
Sorrento Mesa 1,762,709 176,428 79,945 2,019,082 27 54,065 87.7 83.9
Sorrento Valley
3911, 3931, 3985, 4025, 4031, 4045, and 4075 Sorrento Valley Boulevard 191,406 191,406 7 5,916 93.8 93.8
11025, 11035, 11045, 11055, 11065, and 11075 Roselle Street 121,655 121,655 6 3,428 100.0 100.0
Sorrento Valley 313,061 313,061 13 9,344 96.2 96.2
I-15 Corridor
13112 Evening Creek Drive 109,780 109,780 1 2,972 100.0 100.0
I-15 Corridor 109,780 109,780 1 2,972 100.0 100.0
Other 128,745 128,745 1 N/A N/A
San Diego 6,322,521 322,884 208,690 6,854,095 81 236,430 93.3 90.3
Seattle
Lake Union
The Eastlake Life Science Campus by Alexandria 937,290 937,290 8 54,053 97.9 97.9
1165, 1201(1), 1208(1), 1551, and 1616 Eastlake Avenue East, 188 and 199(1) East Blaine Street, and 1600 Fairview Avenue East
400 Dexter Avenue North 290,111 290,111 1 14,820 100.0 100.0
2301 5th Avenue 197,135 197,135 1 9,308 99.0 99.0
219 Terry Avenue North 30,705 30,705 1 1,852 100.0 100.0
601 Dexter Avenue North 18,680 18,680 1 425 100.0 100.0
Lake Union 1,473,921 1,473,921 12 $ 80,458 98.5 % 98.5 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.<br><br>(2)We own 100% of this property. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 35
--- --- Property Listing (continued)
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
Seattle (continued)
SoDo
830 4th Avenue South 42,380 42,380 1 $ 1,479 70.5 % 70.5 %
Elliott Bay
3000/3018 Western Avenue 47,746 47,746 1 1,839 100.0 100.0
410 West Harrison Street and 410 Elliott Avenue West 36,724 36,724 2 912 68.2 68.2
Elliott Bay 84,470 84,470 3 2,751 86.2 86.2
Other 1,027,806 213,976 1,241,782 24 21,131 96.4 79.8
Seattle 2,628,577 213,976 2,842,553 40 105,819 96.8 89.6
Maryland
Rockville
9800, 9804, 9900, 9920, and 9950 Medical Center Drive 560,788 84,264 645,052 8 22,447 95.3 95.3
9704, 9708, 9712, and 9714 Medical Center Drive 215,619 215,619 4 7,937 100.0 100.0
1330 Piccard Drive 131,511 131,511 1 3,926 100.0 100.0
9605 Medical Center Drive 115,691 115,691 1 3,701 100.0 100.0
1500 and 1550 East Gude Drive 90,489 90,489 2 1,411 77.3 77.3
14920 and 15010 Broschart Road 86,703 86,703 2 2,283 100.0 100.0
1405 Research Boulevard 72,170 72,170 1 2,476 100.0 100.0
5 Research Place 63,852 63,852 1 2,743 100.0 100.0
5 Research Court 51,520 51,520 1 1,788 100.0 100.0
9920 Belward Campus Drive 51,181 51,181 1 1,966 100.0 100.0
12301 Parklawn Drive 49,185 49,185 1 1,329 100.0 100.0
Rockville 1,488,709 84,264 1,572,973 23 52,007 96.8 96.8
Gaithersburg
Alexandria Technology Center® – Gaithersburg I 613,438 613,438 9 16,737 98.9 98.9
9, 25, 35, 45, 50, and 55 West Watkins Mill Road and 910, 930, and 940 Clopper Road
Alexandria Technology Center® – Gaithersburg II 315,085 169,420 484,505 7 10,344 99.6 64.8
700, 704, and 708 Quince Orchard Road and 19, 20, 21, and 22 Firstfield Road
20400 Century Boulevard 80,550 80,550 1 N/A
401 Professional Drive 63,154 63,154 1 1,888 100.0 100.0
950 Wind River Lane 50,000 50,000 1 1,004 100.0 100.0
620 Professional Drive 27,950 27,950 1 1,207 100.0 100.0
Gaithersburg 1,069,627 249,970 1,319,597 20 31,180 99.2 80.4
Beltsville
8000/9000/10000 Virginia Manor Road 191,884 191,884 1 2,771 96.7 96.7
Northern Virginia
14225 Newbrook Drive 248,186 248,186 1 6,127 100.0 100.0
Maryland 2,998,406 84,264 249,970 3,332,640 45 $ 92,085 97.9 % 90.4 % Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 36
--- --- Property Listing (continued)
---
March 31, 2021
(Dollars in thousands) Market / Submarket / Address RSF Number of Properties Annual Rental Revenue Occupancy Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Operating Operating and Redevelopment
Operating Development Redevelopment Total
Research Triangle
Research Triangle
Alexandria Center® for Life Science – Durham 1,585,766 652,381 2,238,147 16 $ 26,574 85.3 % 60.5 %
6, 8, 10, 12, 14, 40, 41, 42, and 65 Moore Drive, 21, 25, 27, 29, and 31 Parmer Way, 2400 Ellis Road, and 14 TW Alexander Drive
Alexandria Center® for Advanced Technologies 100,000 250,000 350,000 3 2,229 97.2 97.2
6, 8, and 10 Davis Drive
Alexandria Center® for AgTech 180,400 160,000 340,400 2 6,646 95.2 95.2
5 and 9 Laboratory Drive
Alexandria Technology Center® – Alston 186,870 186,870 3 3,972 92.5 92.5
100, 800, and 801 Capitola Drive
108/110/112/114 TW Alexander Drive 158,417 158,417 1 5,344 100.0 100.0
Alexandria Innovation Center® – Research Triangle 136,455 136,455 3 4,111 100.0 100.0
7010, 7020, and 7030 Kit Creek Road
7 Triangle Drive 96,626 96,626 1 3,156 100.0 100.0
2525 East NC Highway 54 82,996 82,996 1 3,651 100.0 100.0
407 Davis Drive 81,956 81,956 1 1,644 100.0 100.0
601 Keystone Park Drive 77,395 77,395 1 1,375 100.0 100.0
6040 George Watts Hill Drive 61,547 61,547 1 2,148 100.0 100.0
5 Triangle Drive 32,120 32,120 1 1,137 100.0 100.0
6101 Quadrangle Drive 30,122 30,122 1 540 100.0 100.0
Research Triangle 2,810,670 410,000 652,381 3,873,051 35 62,527 90.8 73.7
Canada 256,967 256,967 3 5,151 81.6 81.6
Non-cluster/other markets 550,870 550,870 12 11,478 52.6 52.6
North America, excluding properties held for sale 33,688,520 1,972,422 2,030,091 37,691,033 356 1,533,122 94.5 % 89.2 %
Properties held for sale 225,849 225,849 4 6,231 51.1 % 51.1 %
Total – North America 33,914,369 1,972,422 2,030,091 37,916,882 360 $ 1,539,353 Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 37
--- ---
Investments in Real Estate
---
March 31, 2021
(Dollars in thousands)

As of April 26, 2021, construction activities were in process at all of our active construction projects. Construction workers continue to observe social distancing and follow rules that restrict gatherings of large groups of people in close proximity, as well as adhere to other appropriate measures, which may slow the pace of construction.

Development and Redevelopment
Operating Under Construction Near<br>Term Intermediate<br>Term Future Subtotal Total
Investments in real estate
Book value as of March 31, 2021(1) $ 19,137,741 $ 2,071,733 $ 977,609 $ 596,524 $ 753,057 $ 4,398,923 $ 23,536,664
Square footage
Operating 33,914,369 33,914,369
New Class A development and redevelopment properties 4,002,513 4,612,656 3,826,115 9,221,297 21,662,581 21,662,581
Value-creation square feet currently included in rental properties(2) (553,693) (622,000) (1,810,218) (2,985,911) (2,985,911)
Total square footage 33,914,369 4,002,513 4,058,963 3,204,115 7,411,079 18,676,670 52,591,039

(1)Balances exclude our share of the cost basis associated with our properties held by our unconsolidated real estate joint ventures, which is classified as investments in unconsolidated real estate joint ventures in our consolidated balance sheets. Refer to “Investments in real estate” in the “Definitions and reconciliations” of this Supplemental Information for reconciliation detail of investments in real estate.

(2)Refer to “Investments in real estate” in the “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 38
New Class A Development and Redevelopment Properties: Recent Deliveries
---
March 31, 2021
(Dollars in thousands) Alexandria Center® for Life Science –<br><br>San Carlos 9877 Waples Street 1165 Eastlake Avenue East 9804 Medical Center Drive
--- --- --- ---
San Francisco Bay Area/Greater Stanford San Diego/Sorrento Mesa Seattle/Lake Union Maryland/Rockville
196,020 RSF 63,774 RSF 100,086 RSF 176,832 RSF
Property/Market/Submarket Our Ownership Interest RSF Placed in Service Occupancy Percentage(1) Total Project Unlevered Yields
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Delivery Date 4Q20 1Q21 Total Initial Stabilized Initial Stabilized (Cash Basis)
RSF Investment
Development projects
Alexandria Center® for Life Science – San Carlos/<br><br>San Francisco Bay Area/Greater Stanford Various 100% 96,463 99,557 196,020 100% 526,178 $ 630,000 6.4 % 6.1 %
1165 Eastlake Avenue East/Seattle/Lake Union March 2021 100% 100,086 100,086 100% 100,086 138,000 6.3 (2) 6.4 (2)
9804 Medical Center Drive/Maryland/Rockville January 2021 100% 176,832 176,832 100% 176,832 89,300 (3) 8.3 (3) 8.0 (3)
Redevelopment projects
Alexandria Center® for Life Science – Long Island City/<br><br>New York City/New York City December 2020 100% 17,716 17,716 100% 176,759 184,300 5.5 5.6
9877 Waples Street/San Diego/Sorrento Mesa December 2020 100% 63,774 63,774 100% 63,744 31,000 8.8 8.1
Total 177,953 376,475 554,428 $ 1,072,600 6.5 % 6.3 %

(1)Relates to total operating RSF placed in service as of the most recent delivery.

(2)Unlevered yields represent aggregate returns for 1165 Eastlake Avenue East, an amenity-rich research headquarters for Adaptive Biotechnologies Corporation, and 1208 Eastlake Avenue East, an adjacent multi-tenant office/laboratory building.

(3)Improvements in initial stabilized yields of 60 bps and 80 bps (cash basis) were driven by overall cost savings relative to initial budget.

Refer to “New Class A development and redevelopment properties: current projects” of this Supplemental Information for details on the RSF in service and under construction, if applicable.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 39
New Class A Development and Redevelopment Properties: Current Projects
---
March 31, 2021
The Arsenal on the Charles 201 Brookline Avenue 840 Winter Street 201 Haskins Way
--- --- --- ---
Greater Boston/<br>Cambridge/Inner Suburbs Greater Boston/Fenway Greater Boston/Route 128 San Francisco Bay Area/South San Francisco
360,545 RSF 510,116 RSF 130,000 RSF 315,000 RSF
Alexandria Center® for Life Science –<br><br>San Carlos 3160 Porter Drive Alexandria Center® for Life Science –<br><br>Long Island City 3115 Merryfield Row
--- --- --- ---
San Francisco Bay Area/Greater Stanford San Francisco Bay Area/Greater Stanford New York City/New York City San Diego/Torrey Pines
330,158 RSF 92,147 RSF 122,382 RSF 146,456 RSF Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 40
--- --- New Class A Development and Redevelopment Properties: Current Projects (continued)
---
March 31, 2021 SD Tech by Alexandria(1) 5505 Morehouse Drive 9950 Medical Center Drive 700 Quince Orchard Road
--- --- --- ---
San Diego/Sorrento Mesa San Diego/Sorrento Mesa Maryland/Rockville Maryland/Gaithersburg
176,428 RSF 79,945 RSF 84,264 RSF 169,420 RSF 20400 Century Boulevard Alexandria Center® for Life Science – Durham(2) Alexandria Center® for AgTech Alexandria Center® for<br><br>Advanced Technologies(3)
--- --- --- ---
Maryland/Gaithersburg Research Triangle/Research Triangle Research Triangle/Research Triangle Research Triangle/Research Triangle
80,550 RSF 652,381 RSF 160,000 RSF 250,000 RSF

(1)Represents 10055 Barnes Canyon Road in our SD Tech by Alexandria campus.

(2)Represents 2400 Ellis Road in our Alexandria Center® for Life Science – Durham campus.

(3)Represents 10 Davis Drive in our Alexandria Center® for Advanced Technologies campus.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 41
New Class A Development and Redevelopment Properties: Current Projects (continued)
---
March 31, 2021 Property/Market/Submarket Square Footage Percentage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Dev/Redev In Service CIP Total Leased Leased/Negotiating Initial<br><br>Occupancy(1)
Under construction
The Arsenal on the Charles/Greater Boston/Cambridge/Inner Suburbs Redev 475,743 360,545 836,288 79 % 85 % 2021
201 Haskins Way/San Francisco Bay Area/South San Francisco Dev 315,000 315,000 100 100 2Q21
Alexandria Center® for Life Science – San Carlos/San Francisco Bay Area/<br><br>Greater Stanford Dev 196,020 330,158 526,178 100 100 4Q20
3160 Porter Drive/San Francisco Bay Area/Greater Stanford Redev 92,147 92,147 20 26 1H21
Alexandria Center® for Life Science – Long Island City/New York City/New York City Redev 54,377 122,382 176,759 31 44 4Q20
3115 Merryfield Row/San Diego/Torrey Pines Dev 146,456 146,456 100 100 2022
5505 Morehouse Drive/San Diego/Sorrento Mesa Redev 79,945 79,945 35 35 2021
Other/Seattle Redev 246,647 213,976 460,623 51 51 2022
9950 Medical Center Drive/Maryland/Rockville Dev 84,264 84,264 100 100 1H22 (2)
700 Quince Orchard Road/Maryland/Gaithersburg Redev 169,420 169,420 100 100 2021
Alexandria Center® for Life Science – Durham/Research Triangle/<br><br>Research Triangle(3) Redev 652,381 652,381 77 77 1H21/2022
Alexandria Center® for AgTech/Research Triangle/Research Triangle(4) Redev/Dev 180,400 160,000 340,400 55 55 2021
Alexandria Center® for Advanced Technologies/Research Triangle/<br><br>Research Triangle Dev 250,000 250,000 (5) 58 (5) 58 (5) 2H21/2022
1,153,187 2,976,674 4,129,861 74 76
Under construction – additions in 1Q21
201 Brookline Avenue/Greater Boston/Fenway Dev 510,116 510,116 17 84 2022
840 Winter Street/Greater Boston/Route 128 Redev 30,009 130,000 160,009 19 19 2022
SD Tech by Alexandria/San Diego/Sorrento Mesa Dev 176,428 176,428 61 96 2022
Other/San Diego Redev 128,745 128,745 100 100 2021
20400 Century Boulevard/Maryland/Gaithersburg Redev 80,550 80,550 12 2022
30,009 1,025,839 1,055,848 34 73
1,183,196 4,002,513 5,185,709 66 76
Pre-leased near-term projects
Alexandria Point/San Diego/University Town Center(6) Dev 171,102 171,102 100 100
1,183,196 4,173,615 5,356,811 67 % 76 %

(1)Initial occupancy dates are subject to leasing and/or market conditions. Construction disruptions resulting from COVID-19 and observance of social distancing measures may impact construction and occupancy forecasts and will continue to be monitored closely. Multi-tenant projects may have occupancy by tenants over a period of time. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy.

(2)Refer to footnote 1 on the following page for additional details.

(3)The recently acquired Alexandria Center® for Life Science – Durham redevelopment project includes three properties at 40 Moore Drive, 2400 Ellis Road, and 14 TW Alexander Drive. 2400 Ellis Road is 100% leased, with initial occupancy anticipated in 1H21 and stabilized occupancy expected for the remaining buildings in 2022.

(4)The new strategic collaborative agtech campus consists of Phase I at 5 Laboratory Drive, including campus amenities, which was previously delivered, and Phase II at 9 Laboratory Drive.

(5)Represents 150,000 RSF that is 29% leased at 8 Davis Drive and 100,000 RSF that is 100% leased at 10 Davis Drive. Vertical construction at 8 Davis Drive has commenced, and 10 Davis Drive is expected to commence in 2Q21.

(6)Represents our 4150 Campus Point Court property, which is expected to commence vertical construction in 4Q21.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 42
New Class A Development and Redevelopment Properties: Current Projects (continued)
---
March 31, 2021
(Dollars in thousands)
Our Ownership Interest Unlevered Yields
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Property/Market/Submarket In Service CIP Cost to Complete Total at<br>Completion Initial Stabilized Initial Stabilized (Cash Basis)
Under construction
The Arsenal on the Charles/Greater Boston/Cambridge/Inner Suburbs 100 % $ 357,448 $ 248,243 $ 166,309 $ 772,000 6.2 % 5.5 %
201 Haskins Way/San Francisco Bay Area/South San Francisco 100 % 291,082 $ 78,918 $ 370,000 6.4 % 6.2 %
Alexandria Center® for Life Science – San Carlos/San Francisco Bay Area/<br><br>Greater Stanford 100 % 182,558 340,378 $ 107,064 $ 630,000 6.4 % 6.1 %
3160 Porter Drive/San Francisco Bay Area/Greater Stanford 100 % 74,864 TBD
Alexandria Center® for Life Science – Long Island City/New York City/New York City 100 % 36,560 127,232 $ 20,508 $ 184,300 5.5 % 5.6 %
3115 Merryfield Row/San Diego/Torrey Pines 100 % 72,464 $ 79,536 $ 152,000 6.2 % 6.2 %
5505 Morehouse Drive/San Diego/Sorrento Mesa 100 % 21,950 TBD
Other/Seattle 100 % 54,152 65,329
9950 Medical Center Drive/Maryland/Rockville 100 % 41,154 $ 18,446 $ 59,600 8.6 % (1) 7.7 % (1)
700 Quince Orchard Road/Maryland/Gaithersburg 100 % 49,561 $ 29,939 $ 79,500 8.6 % 7.3 %
Alexandria Center® for Life Science – Durham/Research Triangle/Research Triangle 100 % 143,036 $ 101,964 $ 245,000 7.5 % 6.7 %
Alexandria Center® for AgTech/Research Triangle/Research Triangle 100 % 90,677 69,548 TBD
Alexandria Center® for Advanced Technologies/Research Triangle/Research Triangle 100 % 46,612
721,395 1,591,453
Under construction – additions in 1Q21
201 Brookline Avenue/Greater Boston/Fenway 97.9 % 370,409 TBD
840 Winter Street/Greater Boston/Route 128 100 % 12,517 47,979
SD Tech by Alexandria/San Diego/Sorrento Mesa 50.0 % 25,117
Other/San Diego 100 % 27,855
20400 Century Boulevard/Maryland/Gaithersburg 100 % 8,920
12,517 480,280
733,912 2,071,733
Pre-leased near-term projects
Alexandria Point/San Diego/University Town Center 55.0 % 26,342
Total $ 733,912 $ 2,098,075

(1)During 1Q21, we leased the property to a public biotechnology company which resulted in higher rents and our initial stabilized yields increased by 130 bps and 90 bps (cash basis), and our date of initial occupancy has been revised to 1H22.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 43
New Class A Development and Redevelopment Properties: Summary of Pipeline
---
March 31, 2021
(Dollars in thousands)
Property/Submarket Our Ownership Interest Book Value Square Footage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Development and Redevelopment
Under Construction Near<br>Term Intermediate<br>Term Future Total
Greater Boston
The Arsenal on the Charles/Cambridge/Inner Suburbs 100 % $ 273,891 360,545 200,000 (1) 12,502 573,047
Alexandria Center® for Life Science – Fenway/Fenway (2) 493,272 510,116 305,000 815,116
840 Winter Street/Route 128 100 % 47,979 130,000 130,000
325 Binney Street/Cambridge 100 % 154,591 450,000 (1) 450,000
57 Coolidge Avenue/Cambridge/Inner Suburbs 75.0 % 48,618 275,000 (1) 275,000
15 Necco Street/Seaport Innovation District 96.4 % 188,131 350,000 (1) 350,000
Reservoir Woods/Route 128 100 % 43,040 202,428 (1)(3) 752,845 (3) 955,273
10 Necco Street/Seaport Innovation District 100 % 91,872 175,000 175,000
215 Presidential Way/Route 128 100 % 6,808 112,000 112,000
Alexandria Technology Square®/Cambridge 100 % 7,881 100,000 100,000
380 and 420 E Street/Seaport Innovation District 100 % 117,197 1,000,000 (3) 1,000,000
99 A Street/Seaport Innovation District 95.3 % 45,335 235,000 235,000
One Upland Road and 100 Tech Drive/Route 128 100 % 8,696 750,000 750,000
231 Second Avenue/Route 128 100 % 1,093 32,000 32,000
Other value-creation projects 100 % 9,782 16,955 16,955
1,538,186 1,000,661 1,477,428 592,000 2,899,302 5,969,391
San Francisco Bay Area
201 Haskins Way/South San Francisco 100 % 291,082 315,000 315,000
Alexandria Center® for Life Science – San Carlos/<br><br>Greater Stanford 100 % 597,906 330,158 700,000 (3) 587,000 (3) 1,617,158
3160 Porter Drive/Greater Stanford 100 % 74,864 92,147 92,147
Alexandria Technology Center® – Gateway/South San Francisco 45.9 % 55,147 517,010 (1)(3) 291,000 808,010
901 California Avenue/Greater Stanford 100 % 713 56,924 56,924
88 Bluxome Street/SoMa 100 % 306,754 1,070,925 1,070,925
1450 Owens Street/Mission Bay 100 % 58,004 191,000 191,000
3825 and 3875 Fabian Way/Greater Stanford 100 % 250,000 (3) 228,000 (3) 478,000
3450 and 3460 Hillview Avenue/Greater Stanford 100 % 76,951 (3) 76,951
East Grand Avenue/South San Francisco 100 % 6,120 90,000 90,000
Other value-creation projects 100 % 25,000 25,000
$ 1,390,590 737,305 1,644,859 1,217,951 1,221,000 4,821,115
(1)We expect to commence vertical construction or redevelopment of all or a portion of this project in 2021.<br><br>(2)We have a 97.9% ownership interest in 201 Brookline Avenue which is currently under construction. We have a 100% ownership interest in the intermediate-term development project.<br><br>(3)Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property, and commence future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 44
--- ---
New Class A Development and Redevelopment Properties: Summary of Pipeline (continued)
---
March 31, 2021
(Dollars in thousands)
Property/Submarket Our Ownership Interest Book Value Square Footage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Development and Redevelopment
Under Construction Near<br>Term Intermediate<br>Term Future Total
New York City
Alexandria Center® for Life Science – Long Island City/New York City 100 % $ 127,232 122,382 122,382
47-50 30th Street/New York City 100 % 29,771 135,938 135,938
Alexandria Center® for Life Science – New York City/New York City 100 % 62,078 550,000 (1) 550,000
219 East 42nd Street/New York City 100 % 579,947 (2) 579,947
219,081 122,382 135,938 550,000 579,947 1,388,267
San Diego
3115 Merryfield Row/Torrey Pines 100 % 72,464 146,456 146,456
SD Tech by Alexandria/Sorrento Mesa 50.0 % 109,519 176,428 190,074 (3) 160,000 333,845 860,347
5505 Morehouse Drive/Sorrento Mesa 100 % 21,950 79,945 79,945
Alexandria Point/University Town Center 55.0 % 105,773 351,102 (3) 249,164 (4) 320,281 (4) 920,547
10931 and 10933 Torrey Pines Road/Torrey Pines 100 % 242,000 (4) 242,000
University District/University Town Center 100 % 60,009 600,000 (4)(5) 600,000
11255 and 11355 North Torrey Pines Road/Torrey Pines 100 % 108,183 240,000 (4) 240,000
5200 Illumina Way/University Town Center 51.0 % 12,444 451,832 451,832
6450 Sequence Drive and Excess Land/Sorrento Mesa 100 % 36,312 911,915 (4) 911,915
4045 and 4075 Sorrento Valley Boulevard/Sorrento Valley 100 % 7,679 149,000 (4) 149,000
Other value-creation projects 100 % 27,855 128,745 50,000 178,745
562,188 531,574 541,176 1,251,164 2,456,873 4,780,787
Seattle
1150 Eastlake Avenue East/Lake Union 100 % 56,101 310,000 (3) 310,000
701 Dexter Avenue North/Lake Union 100 % 58,136 217,000 217,000
601 Dexter Avenue North/Lake Union 100 % 36,073 188,400 (4) 188,400
1010 4th Avenue South/SoDo 100 % 49,830 544,825 544,825
830 4th Avenue South/SoDo 100 % 52,488 (4) 52,488
Other value-creation projects 100 % 71,319 213,976 51,255 (4) 35,000 300,231
$ 271,459 213,976 578,255 820,713 1,612,944
(1)We are currently negotiating a long-term ground lease with the City of New York for the future site of a new building approximating 550,000 RSF.<br><br>(2)Includes 349,947 RSF in operation with an opportunity to either convert the existing office space into office/laboratory space through future redevelopment or to expand the building by an additional 230,000 RSF through ground-up development. The building is currently occupied by Pfizer Inc. with a remaining lease term of approximately four years.<br><br>(3)We expect to commence vertical construction or redevelopment of all or a portion of this project during 2021.<br><br>(4)Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property, and commence future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.<br><br>(5)Includes our recently acquired project at 4555 Executive Drive and 9363, 9373, and 9393 Towne Centre Drive in our University Town Center submarket, which is currently under evaluation for development, subject to future market conditions. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 45
--- ---
New Class A Development and Redevelopment Properties: Summary of Pipeline (continued)
---
March 31, 2021
(Dollars in thousands)
Property/Submarket Our Ownership Interest Book Value Square Footage
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Development and Redevelopment
Under Construction Near<br>Term Intermediate<br>Term Future Total
Maryland
9950 Medical Center Drive/Rockville 100 % $ 41,154 84,264 84,264
700 Quince Orchard Road/Gaithersburg 100 % 49,561 169,420 169,420
20400 Century Boulevard/Gaithersburg 100 % 8,920 80,550 80,550
14200 Shady Grove Road/Rockville 100 % 29,621 145,000 145,000 145,000 435,000
9808 Medical Center Drive/Rockville 100 % 2,896 90,000 (1) 90,000
132,152 334,234 235,000 145,000 145,000 859,234
Research Triangle
Alexandria Center® for Life Science – Durham/Research Triangle 100 % 143,036 652,381 652,381
Alexandria Center® for Advanced Technologies/Research Triangle 100 % 63,602 250,000 70,000 700,000 1,020,000
Alexandria Center® for AgTech, Phase II/Research Triangle 100 % 69,548 160,000 160,000
Other value-creation projects 100 % 4,185 76,262 76,262
280,371 1,062,381 70,000 776,262 1,908,643
Other value-creation projects 100 % 4,896 322,200 322,200
Total pipeline as of March 31, 2021 $ 4,398,923 4,002,513 4,612,656 3,826,115 9,221,297 21,662,581 (2)
Key pending acquisition
Mercer Mega Block/Lake Union 800,000 800,000
4,002,513 5,412,656 3,826,115 9,221,297 22,462,581

(1)We expect to commence vertical construction or redevelopment of all or a portion of this project during 2021.

(2)Total square footage includes 2,985,911 RSF of buildings currently in operation that will be redeveloped or replaced with new development RSF upon commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 46
Construction Spending
---
March 31, 2021
(In thousands)
Three Months Ended
--- --- ---
Construction Spending March 31, 2021
Additions to real estate – consolidated projects $ 465,411
Contributions from noncontrolling interests (6,576)
Construction spending (cash basis) 458,835
Change in accrued construction (10,036)
Construction spending 448,799
Projected construction spending for the nine months ending December 31, 2021 1,291,201
Guidance midpoint $ 1,740,000 Year Ending
--- --- ---
Projected Construction Spending December 31, 2021
Development, redevelopment, and pre-construction projects $ 1,625,000
Contributions from noncontrolling interests (consolidated real estate joint ventures) (100,000)
Revenue-enhancing and repositioning capital expenditures 150,000
Non-revenue-enhancing capital expenditures 65,000
Guidance midpoint $ 1,740,000
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 47
--- ---
Joint Venture Financial Information
---
March 31, 2021
Consolidated Real Estate Joint Ventures
--- --- --- --- --- --- --- --- ---
Property Market Submarket Noncontrolling<br><br>Interest Share(1) Operating RSF<br><br>at 100%
75/125 Binney Street Greater Boston Cambridge/Inner Suburbs 60.0% 388,270
225 Binney Street Greater Boston Cambridge/Inner Suburbs 70.0% 305,212
57 Coolidge Avenue Greater Boston Cambridge/Inner Suburbs 25.0% (2)
409 and 499 Illinois Street San Francisco Bay Area Mission Bay 40.0% 455,069
1500 Owens Street San Francisco Bay Area Mission Bay 49.9% 158,267
Alexandria Technology Center® – Gateway(3) San Francisco Bay Area South San Francisco 54.1% 1,089,852
500 Forbes Boulevard San Francisco Bay Area South San Francisco 90.0% 155,685
Alexandria Center® for Life Science – Millbrae Station San Francisco Bay Area South San Francisco 64.5%
Alexandria Point(4) San Diego University Town Center 45.0% 1,337,916
5200 Illumina Way San Diego University Town Center 49.0% 792,687
9625 Towne Centre Drive San Diego University Town Center 49.9% 163,648
SD Tech by Alexandria(5) San Diego Sorrento Mesa 50.0% 677,597
The Eastlake Life Science Campus by Alexandria(6) Seattle Lake Union 70.0% 321,218
Unconsolidated Real Estate Joint Ventures
Property Market Submarket Our Ownership Share(7) Operating RSF<br><br>at 100%
1655 and 1725 Third Street San Francisco Bay Area Mission Bay 10.0 % 586,208
Menlo Gateway San Francisco Bay Area Greater Stanford 49.0 % 772,983

(1)In addition to the consolidated real estate joint ventures listed, various partners hold insignificant noncontrolling interests in six other real estate joint ventures in North America.

(2)We expect to commence vertical construction of 275,000 RSF during 2021.

(3)Excludes 600, 630, 650, 901, and 951 Gateway Boulevard in our South San Francisco submarket. Noncontrolling interest share is anticipated to be 49% as we make further contributions into the joint venture over time.

(4)Excludes 9880 Campus Point Drive in our University Town Center submarket.

(5)Excludes 5505 Morehouse Drive and 10121 and 10151 Barnes Canyon Road in our Sorrento Mesa submarket.

(6)Excludes 1165, 1551, and 1616 Eastlake Avenue East, 188 East Blaine Street, and 1600 Fairview Avenue East in our Lake Union submarket.

(7)In addition to the unconsolidated real estate joint ventures listed, we hold an interest in two other insignificant unconsolidated real estate joint ventures in North America.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 48
Joint Venture Financial Information (continued)
---
March 31, 2021
(Dollars in thousands)
As of March 31, 2021
--- --- --- --- ---
Noncontrolling Interest Share of Consolidated <br>Real Estate JVs Our Share of Unconsolidated Real <br>Estate JVs
Investments in real estate $ 1,605,686 $ 466,268
Cash, cash equivalents, and restricted cash 53,386 9,390
Other assets 215,438 58,946
Secured notes payable (refer to page 53) (202,710)
Other liabilities (82,954) (5,966)
Redeemable noncontrolling interests (11,454)
$ 1,780,102 $ 325,928
Three Months Ended March 31, 2021
--- --- --- ---
Noncontrolling Interest <br>Share of Consolidated <br>Real Estate JVs Our Share of Unconsolidated Real <br>Estate JVs
Total revenues $ 44,762 $ 10,512
Rental operations (12,015) (1,546)
32,747 8,966
General and administrative (109) (30)
Interest (2,323)
Depreciation and amortization (15,443) (3,076)
Fixed returns allocated to redeemable noncontrolling interests(1) 217
$ 17,412 $ 3,537
Straight-line rent and below-market lease revenue $ 855 $ 998
Funds from operations(2) $ 32,855 $ 6,613

(1)Represents an allocation of joint venture earnings to redeemable noncontrolling interests primarily in one property in our South San Francisco submarket. These redeemable noncontrolling interests earn a fixed return on their investment rather than participate in the operating results of the property.

(2)Refer to “Funds from operations and funds from operations per share” in our Earnings Press Release and “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in “Definitions and reconciliations” of this Supplemental Information for the definition and reconciliation from the most directly comparable financial measure presented in accordance with GAAP.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 49
Investments
---
March 31, 2021
(Dollars in thousands)

We present our equity investments at fair value whenever fair value or net asset value (“NAV”) is readily available. Adjustments for our limited partnership investments represent changes in reported NAV as a practical expedient to estimate fair value. For investments without readily available fair values, we adjust the carrying amount whenever such investments have an observable price change, and further adjustments are not made until another price change, if any, is observed. Refer to “Investments” in the “Definitions and reconciliations” of this Supplemental Information for additional details.

Three Months Ended March 31, 2021 Year Ended December 31, 2020
Realized gains $ 47,265 (1) $ 47,288 (2)
Unrealized (losses) gains (46,251) 374,033
Investment income $ 1,014 $ 421,321 Investments Cost Unrealized<br>Gains Carrying Amount
--- --- --- --- --- --- --- --- ---
Fair value:
Publicly traded companies $ 234,146 $ 322,871 (3) $ 557,017
Entities that report NAV 348,207 327,831 676,038
Entities that do not report NAV:
Entities with observable price changes 51,816 78,723 130,539
Entities without observable price changes 278,217 278,217
March 31, 2021 $ 912,386 (4) $ 729,425 $ 1,641,811
December 31, 2020 $ 835,438 $ 775,676 $ 1,611,114

(1)Includes $22.9 million of realized gain related to the acquisition of one of our privately held non-real estate investments in a biopharmaceutical company by a pharmaceutical company.

(2)Includes impairments of $24.5 million related to investments in privately held entities that do not report NAV.

(3)Includes gross unrealized gains and losses of $346.3 million and $23.4 million, respectively, as of March 31, 2021.

(4)Represents 3.2% of total gross assets as of March 31, 2021.

Public/Private<br>Mix (Cost)
Tenant/Non-Tenant<br>Mix (Cost)
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 50
--- ---
Key Credit Metrics
---
March 31, 2021
Liquidity Minimal Outstanding Borrowings and Significant Availability on Unsecured Senior Line of Credit
--- --- ---
(in millions)
4.3B q121lineofcreditv21a.jpg
(in millions)
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program 3,000
Outstanding forward equity sales agreements(1)
Cash, cash equivalents, and restricted cash
Investments in publicly traded companies
Liquidity as of March 31, 2021 4,324
Net Debt and Preferred Stock to Adjusted EBITDA(2) Fixed-Charge Coverage Ratio(2)

All values are in US Dollars.

(1)Represents expected net proceeds from the future settlement of the remaining 1.5 million shares outstanding under our forward equity sales agreements as of March 31, 2021.

(2)Quarter annualized. Refer to “Fixed-charge coverage ratio” and “Net debt and preferred stock to Adjusted EBITDA” in the “Definitions and reconciliations” of this Supplemental Information for additional details.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 51
Summary of Debt
---
March 31, 2021
(in millions)

Weighted-Average Remaining Term of 13.0 Years

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 52
Summary of Debt (continued)
---
March 31, 2021
(Dollars in thousands)
Fixed-rate and variable-rate debt Fixed-Rate<br>Debt Variable-Rate Debt Total Percentage Weighted-Average
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Interest Rate(1) Remaining Term<br>(in years)
Secured notes payable $ 229,406 $ $ 229,406 2.7 % 3.53 % 3.2
Unsecured senior notes payable 8,311,512 8,311,512 97.3 3.54 13.3
Unsecured senior line of credit N/A 4.8
Commercial paper program N/A (2)
Total/weighted average $ 8,540,918 $ $ 8,540,918 100.0 % 3.54 % 13.0
Percentage of total debt 100 % % 100 %

(1)Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to the amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

(2)The commercial paper notes bear interest at short-term fixed rates and can generally be issued with a maturity of 30 days or less and with a maximum maturity of 397 days from the date of issuance. Borrowings under the program are used to fund short-term capital needs and are backed by our unsecured senior line of credit. In the event we are unable to issue commercial paper notes or refinance outstanding borrowings under terms equal to or more favorable than those under our unsecured senior line of credit, we expect to borrow under the unsecured senior line of credit at L+0.815%. As such, we calculate the weighted-average remaining term of our commercial paper by using the maturity date of our unsecured senior line of credit. The commercial paper notes sold during the three months ended March 31, 2021, were issued at a weighted-average yield to maturity of 0.22% and had a weighted-average maturity term of 10 days.

Debt covenants Unsecured Senior Notes Payable Unsecured Senior Line of Credit
Debt Covenant Ratios(1) Requirement March 31, 2021 Requirement March 31, 2021
Total Debt to Total Assets ≤ 60% 31% ≤ 60.0% 29.1%
Secured Debt to Total Assets ≤ 40% 1% ≤ 45.0% 0.8%
Consolidated EBITDA to Interest Expense ≥ 1.5x 9.8x ≥ 1.50x 4.01x
Unencumbered Total Asset Value to Unsecured Debt ≥ 150% 298% N/A N/A
Unsecured Interest Coverage Ratio N/A N/A ≥ 1.75x 7.36x

(1)All covenant ratio titles utilize terms as defined in the respective debt and credit agreements. The calculation of consolidated EBITDA is based on the definitions contained in our loan agreements and is not directly comparable to the computation of EBITDA as described in Exchange Act Release No. 47226.

Unconsolidated real estate joint ventures’ debt
Unconsolidated Joint Venture Our Share Maturity Date Stated Rate Interest Rate(1) Debt Balance at 100%(2)
1655 and 1725 Third Street 10.0% 3/10/25 4.50% 4.57% $ 598,338
Menlo Gateway, Phase II 49.0% 5/1/35 4.53% 4.59% 155,965
Menlo Gateway, Phase I 49.0% 8/10/35 4.15% 4.18% 138,905
$ 893,208

(1)Includes interest expense and amortization of loan fees.

(2)Represents outstanding principal, net of unamortized deferred financing costs, as of March 31, 2021.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 53
Summary of Debt (continued)
---
March 31, 2021
(Dollars in thousands)
Debt Stated <br>Rate Interest<br><br>Rate(1) Maturity<br><br>Date(2) Principal Payments Remaining for the Periods Ending December 31, Principal Unamortized (Deferred Financing Cost), (Discount)/Premium Total
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
2021 2022 2023 2024 2025 Thereafter
Secured notes payable
Greater Boston 4.82 % 3.40 % 2/6/24 $ 2,529 $ 3,564 $ 3,742 $ 183,527 $ $ $ 193,362 $ 7,717 $ 201,079
San Francisco Bay Area 4.14 % 4.42 7/1/26 28,200 28,200 (577) 27,623
San Francisco Bay Area 6.50 % 6.50 7/1/36 26 28 30 32 34 554 704 704
Secured debt weighted-average interest rate/subtotal 4.74 % 3.53 2,555 3,592 3,772 183,559 34 28,754 222,266 7,140 229,406
Commercial paper program(3) N/A (3) N/A (3) (3)
Unsecured senior line of credit L+0.815 % (4) N/A 1/6/26
Unsecured senior notes payable 3.45 % 3.62 4/30/25 600,000 600,000 (3,589) 596,411
Unsecured senior notes payable 4.30 % 4.50 1/15/26 300,000 300,000 (2,345) 297,655
Unsecured senior notes payable – green bond 3.80 % 3.96 4/15/26 350,000 350,000 (2,479) 347,521
Unsecured senior notes payable 3.95 % 4.13 1/15/27 350,000 350,000 (2,938) 347,062
Unsecured senior notes payable 3.95 % 4.07 1/15/28 425,000 425,000 (2,881) 422,119
Unsecured senior notes payable 4.50 % 4.60 7/30/29 300,000 300,000 (1,853) 298,147
Unsecured senior notes payable 2.75 % 2.87 12/15/29 400,000 400,000 (3,587) 396,413
Unsecured senior notes payable 4.70 % 4.81 7/1/30 450,000 450,000 (3,443) 446,557
Unsecured senior notes payable 4.90 % 5.05 12/15/30 700,000 700,000 (7,649) 692,351
Unsecured senior notes payable 3.375 % 3.48 8/15/31 750,000 750,000 (6,739) 743,261
Unsecured senior notes payable – green bond 2.00 % 2.12 5/18/32 900,000 900,000 (10,229) 889,771
Unsecured senior notes payable 1.875 % 1.97 2/1/33 1,000,000 1,000,000 (10,345) 989,655
Unsecured senior notes payable 4.85 % 4.93 4/15/49 300,000 300,000 (3,303) 296,697
Unsecured senior notes payable 4.00 % 3.91 2/1/50 700,000 700,000 10,385 710,385
Unsecured senior notes payable 3.00 % 3.08 5/18/51 850,000 850,000 (12,493) 837,507
Unsecured debt weighted average/subtotal 3.54 600,000 7,775,000 8,375,000 (63,488) 8,311,512
Weighted-average interest rate/total 3.54 % $ 2,555 $ 3,592 $ 3,772 $ 183,559 $ 600,034 $ 7,803,754 $ 8,597,266 $ (56,348) $ 8,540,918
Balloon payments $ $ $ $ 183,221 $ 600,000 $ 7,803,200 $ 8,586,421 $ $ 8,586,421
Principal amortization 2,555 3,592 3,772 338 34 554 10,845 (56,348) (45,503)
Total debt $ 2,555 $ 3,592 $ 3,772 $ 183,559 $ 600,034 $ 7,803,754 $ 8,597,266 $ (56,348) $ 8,540,918
Fixed-rate/hedged variable-rate debt $ 2,555 $ 3,592 $ 3,772 $ 183,559 $ 600,034 $ 7,803,754 $ 8,597,266 $ (56,348) $ 8,540,918
Unhedged variable-rate debt
Total debt $ 2,555 $ 3,592 $ 3,772 $ 183,559 $ 600,034 $ 7,803,754 $ 8,597,266 $ (56,348) $ 8,540,918
Weighted-average stated rate on maturing debt N/A N/A N/A 4.82% 3.45% 3.44%

(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

(2)Reflects any extension options that we control.

(3)Refer to footnote 2 on the prior page under “Fixed-rate and variable-rate debt.”

(4)During 1Q21, we achieved certain sustainability measures, as described in our unsecured senior line of credit agreement, which reduced the borrowing rate by one basis point for one year.

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 54
Definitions and Reconciliations
---
March 31, 2021

This section contains additional details for sections throughout this Supplemental Information and the accompanying Earnings Press Release, as well as explanations and reconciliations of certain non-GAAP financial measures and the reasons why we use these supplemental measures of performance and believe they provide useful information to investors. Additional detail can be found in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.

Adjusted EBITDA and Adjusted EBITDA margin

The following table reconciles net income (loss) and revenues, the most directly comparable financial measures calculated and presented in accordance with GAAP, to Adjusted EBITDA and revenues, as adjusted, respectively:

Three Months Ended
(Dollars in thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Net income $ 25,533 $ 457,133 $ 95,799 $ 243,561 $ 30,678
Interest expense 36,467 37,538 43,318 45,014 45,739
Income taxes 1,426 2,053 2,430 1,406 1,341
Depreciation and amortization 180,913 177,750 176,831 168,027 175,496
Stock compensation expense 12,446 11,394 12,994 9,185 9,929
Loss on early extinguishment of debt 67,253 7,898 52,770
Gain on sales of real estate (2,779) (152,503) (1,586)
Realized gains on non-real estate investments (22,919)
Unrealized losses (gains) on non-real estate investments 46,251 (233,538) 14,013 (171,652) 17,144
Impairment of real estate 5,129 25,177 7,680 13,218 9,647
Impairment of non-real estate investments 4,702 19,780
Termination fee (86,179)
Adjusted EBITDA $ 349,720 $ 332,902 $ 318,070 $ 313,461 $ 309,754
Revenues $ 479,849 $ 463,720 $ 545,042 $ 436,956 $ 439,919
Non-real estate investments – realized gains (losses) 47,265 21,599 17,361 13,005 (4,677)
Realized gains on non-real estate investments (22,919)
Impairment of non-real estate investments 4,702 19,780
Termination fee (86,179)
Revenues, as adjusted $ 504,195 $ 485,319 $ 476,224 $ 454,663 $ 455,022
Adjusted EBITDA margin 69% 69% 67% 69% 68%

We use Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization (“EBITDA”), excluding stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, impairments of real estate, and significant termination fees. Adjusted EBITDA also excludes unrealized gains or losses and significant realized gains and impairments that result from our non-real estate investments. These non-real estate investment amounts are classified in our consolidated statements of operations outside of total revenues.

We believe Adjusted EBITDA provides investors with relevant and useful information as it allows investors to evaluate the operating performance of our business activities without having to account for differences recognized because of investing and financing decisions related to our real estate and non-real estate investments, our capital structure, capital market transactions, and variances resulting from the volatility of market conditions outside of our control. For example, we exclude gains or losses on the early extinguishment of debt to allow investors to measure our performance independent of our indebtedness and capital structure. We believe that adjusting for the effects of impairments and gains or losses on sales of real estate, significant impairments and gains on the sale of non-real estate investments, and significant termination fees allows investors to evaluate performance from period to period on a consistent basis without having to account for differences recognized because of investing and financing decisions related to our real estate and non-real estate investments or other corporate activities that may not be representative of the operating performance of our properties.

In addition, we believe that excluding charges related to stock compensation and unrealized gains or losses facilitates for investors a comparison of our business activities across periods without the volatility resulting from market forces outside of our control. Adjusted EBITDA has limitations as a measure of our performance. Adjusted EBITDA does not reflect our historical expenditures or future requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant measure of performance, it does not represent net income (loss) or cash flows from operations calculated and presented in accordance with GAAP, and it should not be considered as an alternative to those indicators in evaluating performance or liquidity.

In order to calculate Adjusted EBITDA margin, we also make comparable adjustments to our revenues. We adjust our total revenues by realized gains, losses, and impairments related to our non-real estate investments and significant termination fees to arrive at revenues, as adjusted. Our calculation of Adjusted EBITDA margin divides Adjusted EBITDA by our revenues, as adjusted. We believe that consistent application of these comparable adjustments to both components of Adjusted EBITDA margin provides a more useful calculation for the comparison across periods.

Annual rental revenue

Annual rental revenue represents the annualized fixed base rental obligations, calculated in accordance with GAAP, for leases in effect as of the end of the period, related to our operating RSF. Annual rental revenue is presented using 100% of the annual rental revenue of our consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Annual rental revenue per RSF is computed by dividing annual rental revenue by the sum of 100% of the RSF of our consolidated properties and our share of the RSF of properties held in unconsolidated real estate joint ventures. As of March 31, 2021, approximately 94% of our leases (on an RSF basis) were triple net leases, which require tenants to pay substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses (including increases thereto) in addition to base rent. Annual rental revenue excludes these operating expenses recovered from our tenants. Amounts recovered from our tenants related to these operating expenses, along with base rent, are classified in income from rentals in our consolidated statements of operations.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 55 | | --- | --- || Definitions and Reconciliations (continued) | | --- | | March 31, 2021 |

Cash interest

Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of loan fees and debt premiums (discounts). Refer to the definition of fixed-charge coverage ratio for a reconciliation of interest expense, the most directly comparable financial measure calculated and presented in accordance with GAAP, to cash interest.

Class A properties and AAA locations

Class A properties are properties clustered in AAA locations that provide innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Class A properties generally command higher annual rental rates than other classes of similar properties.

AAA locations are in close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses. Such locations are generally characterized by high barriers to entry for new landlords, high barriers to exit for tenants, and a limited supply of available space.

Development, redevelopment, and pre-construction

A key component of our business model is our disciplined allocation of capital to the development and redevelopment of new Class A properties, and property enhancements identified during the underwriting of certain acquired properties, located in collaborative life science, agtech, and technology campuses in AAA innovation clusters. These projects are generally focused on providing high-quality, generic, and reusable spaces that meet the real estate requirements of, and are reusable by, a wide range of tenants. Upon completion, each value-creation project is expected to generate a significant increase in rental income, net operating income, and cash flows. Our development and redevelopment projects are generally in locations that are highly desirable to high-quality entities, which we believe results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Development projects generally consist of the ground-up development of generic and reusable facilities. Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into office/laboratory, agtech, or tech office space. We generally will not commence new development projects for aboveground construction of new Class A office/laboratory, agtech, and tech office space without first securing significant pre-leasing for such space, except when there is solid market demand for high-quality Class A properties.

Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and are required for the vertical construction of buildings. Ultimately, these projects will provide high-quality facilities and are expected to generate significant revenue and cash flows.

Development, redevelopment, and pre-construction spending also includes the following costs: (i) certain tenant improvements and renovations that will be reimbursed, (ii) amounts to bring certain acquired properties up to market standard and/or other costs identified during the acquisition process (generally within two years of acquisition), and (iii) permanent conversion of space for highly flexible, move-in-ready office/laboratory space to foster the growth of promising early- and growth-stage life science companies.

Revenue-enhancing and repositioning capital expenditures represent spending to reposition or significantly change the use of a property, including through improvement in the asset quality from Class B to Class A.

Non-revenue-enhancing capital expenditures represent costs required to maintain the current revenues of a stabilized property, including the associated costs for renewed and re-leased space.

Dividend payout ratio (common stock)

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of common stock outstanding on the respective record dates multiplied by the related dividend per share) to funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted.

Dividend yield

Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end of the quarter.

Fixed-charge coverage ratio

Fixed-charge coverage ratio is a non-GAAP financial measure representing the ratio of Adjusted EBITDA to fixed charges. We believe this ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing obligations and preferred stock dividends. Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of loan fees and debt premiums (discounts).

The following table reconciles interest expense, the most directly comparable financial measure calculated and presented in accordance with GAAP, to cash interest and fixed charges:

Three Months Ended
(Dollars in thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Adjusted EBITDA $ 349,720 $ 332,902 $ 318,070 $ 313,461 $ 309,754
Interest expense $ 36,467 $ 37,538 $ 43,318 $ 45,014 $ 45,739
Capitalized interest 39,886 37,589 32,556 30,793 24,680
Amortization of loan fees (2,817) (2,905) (2,605) (2,737) (2,247)
Amortization of debt premiums 576 869 910 888 888
Cash interest and fixed charges $ 74,112 $ 73,091 $ 74,179 $ 73,958 $ 69,060
Fixed-charge coverage ratio:
– quarter annualized 4.7x 4.6x 4.3x 4.2x 4.5x
– trailing 12 months 4.4x 4.4x 4.3x 4.2x 4.2x
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 56
--- --- Definitions and Reconciliations (continued)
---
March 31, 2021

Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders

GAAP-basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish over time. In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Nareit Board of Governors established funds from operations as an improved measurement tool. Since its introduction, funds from operations has become a widely used non-GAAP financial measure among equity REITs. We believe that funds from operations is helpful to investors as an additional measure of the performance of an equity REIT. Moreover, we believe that funds from operations, as adjusted, allows investors to compare our performance to the performance of other real estate companies on a consistent basis, without having to account for differences recognized because of real estate acquisition and disposition decisions, financing decisions, capital structure, capital market transactions, variances resulting from the volatility of market conditions outside of our control, or other corporate activities that may not be representative of the operating performance of our properties.

The 2018 White Paper published by the Nareit Board of Governors (the “Nareit White Paper”) defines funds from operations as net income (computed in accordance with GAAP), excluding gains or losses on sales of real estate, and impairments of real estate, plus depreciation and amortization of operating real estate assets, and after adjustments for our share of consolidated and unconsolidated partnerships and real estate joint ventures. Impairments represent the write-down of assets when fair value over the recoverability period is less than the carrying value due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.

We compute funds from operations, as adjusted, as funds from operations calculated in accordance with the Nareit White Paper, excluding significant gains, losses, and impairments realized on non-real estate investments, unrealized gains or losses on non-real estate investments, gains or losses on early extinguishment of debt, significant termination fees, acceleration of stock compensation expense due to the resignation of an executive officer, deal costs, the income tax effect related to such items, and the amount of such items that is allocable to our unvested restricted stock awards. Neither funds from operations nor funds from operations, as adjusted, should be considered as alternatives to net income (determined in accordance with GAAP) as indications of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as measures of liquidity, nor are they indicative of the availability of funds for our cash needs, including our ability to make distributions.

The following table reconciles net income to funds from operations for the share of consolidated real estate joint ventures attributable to noncontrolling interests and our share of unconsolidated real estate joint ventures:

Three Months Ended March 31, 2021
(In thousands) Noncontrolling Interest Share of Consolidated Real Estate JVs Our Share of Unconsolidated <br>Real Estate JVs
Net income $ 17,412 $ 3,537
Depreciation and amortization 15,443 3,076
Funds from operations $ 32,855 $ 6,613

Initial stabilized yield (unlevered)

Initial stabilized yield is calculated as the estimated amounts of net operating income at stabilization divided by our investment in the property. Our initial stabilized yield excludes the benefit of leverage. Our cash rents related to our value-creation projects are generally expected to increase over time due to contractual annual rent escalations. Our estimates for initial stabilized yields, initial stabilized yields (cash basis), and total costs at completion represent our initial estimates at the commencement of the project. We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.

•Initial stabilized yield reflects rental income, including contractual rent escalations and any rent concessions over the term(s) of the lease(s), calculated on a straight-line basis.

•Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental concessions, if any, have elapsed and our total cash investment in the property.

Investment-grade or publicly traded large cap tenants

Investment-grade or publicly traded large cap tenants represent tenants that are investment-grade rated or publicly traded companies with an average daily market capitalization greater than $10 billion for the twelve months ended March 31, 2021, as reported by Bloomberg Professional Services. In addition, we monitor the credit quality and related material changes of our tenants. Material changes that cause a tenant’s market capitalization to decline below $10 billion, which are not immediately reflected in the twelve-month average, may result in their exclusion from this measure.

Investments

We hold investments in publicly traded companies and privately held entities primarily involved in the life science, agtech, and technology industries. We recognize, measure, present, and disclose these investments as follows:

Statements of Operations
Balance Sheet Gains and Losses
Carrying Amount Unrealized Realized
Difference between proceeds received upon disposition and historical cost
Publicly traded companies Fair value Changes in fair value
Privately held entities without readily determinable fair values that:
Report NAV Fair value, using NAV as a practical expedient Changes in NAV, as a practical expedient to fair value
Do not report NAV Cost, adjusted for observable price changes and impairments Observable price changes Impairments to reduce costs to fair value, which result in an adjusted cost basis and the differences between proceeds received upon disposition and adjusted or historical cost
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 57
--- --- Definitions and Reconciliations (continued)
---
March 31, 2021

For investments in privately held entities that do not report NAV per share, an observable price is a price observed in an orderly transaction for an identical or similar investment of the same issuer. Observable price changes result from, among other things, equity transactions for the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity transactions related to the same issuer. For these transactions to be considered observable price changes of the same issuer, we evaluate whether these transactions have similar rights and obligations, including voting rights, distribution preferences, conversion rights, and other factors, to the investments we hold.

Investments in real estate

The following table reconciles our investments in real estate as of March 31, 2021:

(In thousands) Investments in Real Estate
Gross investments in real estate $ 23,536,664
Less: accumulated depreciation (3,315,190)
Net investments in real estate – North America 20,221,474
Net investments in real estate – Asia 31,944
Investments in real estate $ 20,253,418
Space Intentionally Blank
---

The square footage presented in the table below includes RSF of buildings in operation as of March 31, 2021, primarily representing lease expirations at recently acquired properties that also have inherent future development or redevelopment opportunities, for which we have the intent to demolish or redevelop the existing property upon expiration of the existing in-place leases and commencement of future construction:

Dev/<br>Redev RSF of Lease Expirations Targeted for<br>Development and Redevelopment
Property/Submarket 2021 2022 Thereafter Total
Near-term projects:
50 and 60 Sylvan Road/Route 128 Redev 202,428 202,428
651 Gateway Boulevard/South San Francisco Redev 198,089 101,921 (1) 300,010
Other/Seattle Redev 51,255 51,255
202,428 249,344 101,921 553,693
Intermediate-term projects:
3825 Fabian Way/Greater Stanford Redev 250,000 250,000
3450 and 3460 Hillview Avenue/Greater Stanford Redev 42,340 34,611 76,951
1075 Commercial Street/Greater Stanford Dev 9,738 9,738
10931 and 10933 North Torrey Pines Road/<br> Torrey Pines Dev 92,450 92,450
10260 Campus Point Drive/University Town Center Dev 109,164 109,164
9393 Towne Centre Drive/University Town Center Dev 42,222 42,222
4555 Executive Drive/University Town Center Dev 41,475 41,475
93,435 384,790 143,775 622,000
Future projects:
380 and 420 E Street/Seaport Innovation District Dev 195,506 195,506
40 Sylvan Road/Route 128 Redev 312,845 312,845
3875 Fabian Way/Greater Stanford Redev 228,000 228,000
960 Industrial Road/Greater Stanford Dev 110,000 110,000
219 East 42nd Street/New York City Dev 349,947 349,947
11255 and 11355 North Torrey Pines Road/<br> Torrey Pines Dev 139,135 139,135
4161 Campus Point Court/University Town Center Dev 159,884 159,884
6450 Sequence Drive/Sorrento Mesa Redev 202,915 202,915
4045 and 4075 Sorrento Valley Boulevard/<br> Sorrento Valley Dev 50,926 50,926
601 Dexter Avenue North/Lake Union Dev 18,680 18,680
830 4th Avenue South/SoDo Dev 42,380 42,380
139,135 1,671,083 1,810,218
295,863 773,269 1,916,779 2,985,911

(1)     Represents vacant square footage as of March 31, 2021.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 58 | | --- | --- || Definitions and Reconciliations (continued) | | --- | | March 31, 2021 |

Joint venture financial information

We present components of balance sheet and operating results information related to our real estate joint ventures, which are not presented, or intended to be presented, in accordance with GAAP. We present the proportionate share of certain financial line items as follows: (i) for each real estate joint venture that we consolidate in our financial statements, which are controlled by us through contractual rights or majority voting rights, but of which we own less than 100%, we apply the noncontrolling interest economic ownership percentage to each financial item to arrive at the amount of such cumulative noncontrolling interest share of each component presented; and (ii) for each real estate joint venture that we do not control and do not consolidate, and are instead controlled jointly or by our joint venture partners through contractual rights or majority voting rights, we apply our economic ownership percentage to each financial item to arrive at our proportionate share of each component presented.

The components of balance sheet and operating results information related to our real estate joint ventures do not represent our legal claim to those items. For each entity that we do not wholly own, the joint venture agreement generally determines what equity holders can receive upon capital events, such as sales or refinancing, or in the event of a liquidation. Equity holders are normally entitled to their respective legal ownership of any residual cash from a joint venture only after all liabilities, priority distributions, and claims have been repaid or satisfied.

We believe this information can help investors estimate the balance sheet and operating results information related to our partially owned entities. Presenting this information provides a perspective not immediately available from consolidated financial statements and one that can supplement an understanding of the joint venture assets, liabilities, revenues, and expenses included in our consolidated results.

The components of balance sheet and operating results information related to our real estate joint ventures are limited as an analytical tool as the overall economic ownership interest does not represent our legal claim to each of our joint ventures’ assets, liabilities, or results of operations. In addition, joint venture financial information may include financial information related to the unconsolidated real estate joint ventures that we do not control. We believe that in order to facilitate for investors a clear understanding of our operating results and our total assets and liabilities, joint venture financial information should be examined in conjunction with our consolidated statements of operations and balance sheets. Joint venture financial information should not be considered an alternative to our consolidated financial statements, which are presented and prepared in accordance with GAAP.

Key items included in net income attributable to Alexandria’s common stockholders

We present a tabular comparison of items, whether gain or loss, that may facilitate a high-level understanding of our results and provide context for the disclosures included in this Supplemental Information, our most recent annual report on Form 10-K, and our subsequent quarterly reports on Form 10-Q. We believe such tabular presentation promotes a better understanding for investors of the corporate-level decisions made and activities performed that significantly affect comparison of our operating results from period to period. We also believe this tabular presentation will supplement for investors an understanding of our disclosures and real estate operating results. Gains or losses on sales of real estate and impairments of held for sale assets are related to corporate-level decisions to dispose of real estate. Gains or losses on early extinguishment of debt are related to corporate-level financing decisions focused on our capital structure strategy. Significant realized and unrealized gains or losses on non-real estate investments and impairments of real estate and non-real estate investments are not related to the operating performance of our real estate assets as they result from strategic, corporate-level non-real estate investment decisions and external market conditions. Impairments of non-real estate investments are not related to the operating performance of our real estate as they represent the write-down of non-real estate investments when their fair values decline below their respective carrying

values due to changes in general market or other conditions outside of our control. Significant items, whether a gain or loss, included in the tabular disclosure for current periods are described in further detail in this Supplemental Information and accompanying Earnings Press Release.

Net cash provided by operating activities after dividends

Net cash provided by operating activities after dividends includes the deduction for distributions to noncontrolling interests. For purposes of this calculation, changes in operating assets and liabilities are excluded as they represent timing differences.

Net debt and preferred stock to Adjusted EBITDA

Net debt and preferred stock to Adjusted EBITDA is a non-GAAP financial measure that we believe is useful to investors as a supplemental measure in evaluating our balance sheet leverage. Net debt and preferred stock is equal to the sum of total consolidated debt less cash, cash equivalents, and restricted cash, plus preferred stock outstanding as of the end of the period. Refer to the definition of Adjusted EBITDA and Adjusted EBITDA margin for further information on the calculation of Adjusted EBITDA.

The following table reconciles debt to net debt and preferred stock and computes the ratio to Adjusted EBITDA:

(Dollars in thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Secured notes payable $ 229,406 $ 230,925 $ 342,363 $ 344,784 $ 347,136
Unsecured senior notes payable 8,311,512 7,232,370 7,230,819 6,738,486 6,736,999
Unsecured senior line of credit and commercial paper 99,991 249,989 440,000 221,000
Unamortized deferred financing costs 68,293 56,312 58,284 52,175 53,807
Cash and cash equivalents (492,184) (568,532) (446,255) (206,860) (445,255)
Restricted cash (42,219) (29,173) (38,788) (34,680) (43,116)
Preferred stock
Net debt and preferred stock $ 8,074,808 $ 7,021,893 $ 7,396,412 $ 7,333,905 $ 6,870,571
Adjusted EBITDA:
– quarter annualized $ 1,398,880 $ 1,331,608 $ 1,272,280 $ 1,253,844 $ 1,239,016
– trailing 12 months $ 1,314,153 $ 1,274,187 $ 1,228,440 $ 1,185,347 $ 1,137,650
Net debt and preferred stock to Adjusted EBITDA:
– quarter annualized 5.8 x 5.3 x 5.8 x 5.8 x 5.5 x
– trailing 12 months 6.1 x 5.5 x 6.0 x 6.2 x 6.0 x
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 59
--- --- Definitions and Reconciliations (continued)
---
March 31, 2021

Net operating income, net operating income (cash basis), and operating margin

The following table reconciles net income to net operating income and to net operating income (cash basis):

Three Months Ended
(Dollars in thousands) 3/31/21 3/31/20
Net income $ 25,533 $ 30,678
Equity in (earnings) losses of unconsolidated real estate joint ventures (3,537) 3,116
General and administrative expenses 33,996 31,963
Interest expense 36,467 45,739
Depreciation and amortization 180,913 175,496
Impairment of real estate 5,129 2,003
Loss on early extinguishment of debt 67,253
Gain on sales of real estate (2,779)
Investment (income) loss (1,014) 21,821
Net operating income 341,961 310,816
Straight-line rent revenue (27,382) (20,597)
Amortization of acquired below-market leases (12,112) (15,964)
Net operating income (cash basis) $ 302,467 $ 274,255
Net operating income (cash basis) – annualized $ 1,209,868 $ 1,097,020
Net operating income (from above) $ 341,961 $ 310,816
Total revenues $ 479,849 $ 439,919
Operating margin 71% 71%

Net operating income is a non-GAAP financial measure calculated as net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, excluding equity in the earnings of our unconsolidated real estate joint ventures, general and administrative expenses, interest expense, depreciation and amortization, impairments of real estate, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, and investment income or loss. We believe net operating income provides useful information to investors regarding our financial condition and results of operations because it primarily reflects those income and expense items that are incurred at the property level. Therefore, we believe net operating income is a useful measure for investors to evaluate the operating performance of our consolidated real estate assets. Net operating income on a cash basis is net operating income adjusted to exclude the effect of straight-line rent and amortization of acquired above- and below-market lease revenue adjustments required by GAAP. We believe that net operating income on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent revenue and the amortization of acquired above- and below-market leases.

Furthermore, we believe net operating income is useful to investors as a performance measure for our consolidated properties because, when compared across periods, net operating income reflects trends in occupancy rates, rental rates, and operating costs, which provide a perspective not immediately apparent from net income or loss. Net operating income can be used to measure the initial stabilized yields of our properties by calculating net operating income generated by a property divided by our investment in the property. Net operating income excludes certain components from net income in order to provide results that are more closely related to the results of operations of our properties. For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level. In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort comparability of operating performance at the property level. Impairments of real estate have been excluded in deriving net operating income because we do not consider impairments of real estate to be property-level operating expenses. Impairments of real estate relate to changes in the values of our assets and do not reflect the current operating performance with respect to related revenues or expenses. Our impairments of real estate represent the write-down in the value of the assets to the estimated fair value less cost to sell. These impairments result from investing decisions or a deterioration in market conditions. We also exclude realized and unrealized investment income or loss, which results from investment decisions that occur at the corporate level related to non-real estate investments in publicly traded companies and certain privately held entities. Therefore, we do not consider these activities to be an indication of operating performance of our real estate assets at the property level. Our calculation of net operating income also excludes charges incurred from changes in certain financing decisions, such as losses on early extinguishment of debt, as these charges often relate to corporate strategy. Property operating expenses included in determining net operating income primarily consist of costs that are related to our operating properties, such as utilities, repairs, and maintenance; rental expense related to ground leases; contracted services, such as janitorial, engineering, and landscaping; property taxes and insurance; and property-level salaries. General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies that are incurred as part of corporate office management. We calculate operating margin as net operating income divided by total revenues.

We believe that in order to facilitate for investors a clear understanding of our operating results, net operating income should be examined in conjunction with net income or loss as presented in our consolidated statements of operations. Net operating income should not be considered as an alternative to net income or loss as an indication of our performance, nor as an alternative to cash flows as a measure of our liquidity or our ability to make distributions.

Operating statistics

We present certain operating statistics related to our properties, including number of properties, RSF, occupancy percentage, leasing activity, and contractual lease expirations as of the end of the period. We believe these measures are useful to investors because they facilitate an understanding of certain trends for our properties. We compute the number of properties, RSF, occupancy percentage, leasing activity, and contractual lease expirations at 100% for all properties in which we have an investment, including properties owned by our consolidated and unconsolidated real estate joint ventures. For operating metrics based on annual rental revenue, refer to our discussion of annual rental revenue herein.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 60 | | --- | --- || Definitions and Reconciliations (continued) | | --- | | March 31, 2021 |

Same property comparisons

As a result of changes within our total property portfolio during the comparative periods presented, including changes from assets acquired or sold, properties placed into development or redevelopment, and development or redevelopment properties recently placed into service, the consolidated total income from rentals, as well as rental operating expenses in our operating results, can show significant changes from period to period. In order to supplement an evaluation of our results of operations over a given quarterly or annual period, we analyze the operating performance for all consolidated properties that were fully operating for the entirety of the comparative periods presented, referred to as same properties. We separately present quarterly and year-to-date same property results to align with the interim financial information required by the SEC in our management’s discussion and analysis of our financial condition and results of operations. These same properties are analyzed separately from properties acquired subsequent to the first day in the earliest comparable quarterly or year-to-date period presented, properties that underwent development or redevelopment at any time during the comparative periods, unconsolidated real estate joint ventures, properties classified as held for sale, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results. Additionally, termination fees, if any, are excluded from the results of same properties.

Space Intentionally Blank

The following table reconciles the number of same properties to total properties for the three months ended March 31, 2021:

Development – under construction Properties Acquisitions after January 1, 2020 Properties
9950 Medical Center Drive 1 3181 Porter Drive 1
Alexandria Center® for Life Science – San Carlos 275 Grove Street 1
2 601, 611, and 651 Gateway Boulevard 3
3115 Merryfield Row 1 3330, 3412, 3450, and 3460 Hillview Avenue
201 Haskins Way 1 4
Alexandria Center® for AgTech 2 9605 Medical Center Drive 1
Alexandria Center® for Advanced Technologies 9808 and 9868 Scranton Road 2
2 1075 Commercial Street 1
201 Brookline Avenue 1 4555 Executive Drive 1
SD Tech by Alexandria 1 Alexandria Center® for Life Science – Durham
11 13
Development – placed into Reservoir Woods 3
service after January 1, 2020 Properties One Upland Road 1
9804 Medical Center Drive 1 830 4th Avenue South 1
1165 Eastlake Avenue East 1 11255 and 11355 North Torrey Pines Road
2 2
Redevelopment – under construction Properties 6420 and 6450 Sequence Drive 2
5505 Morehouse Drive 1 380 and 420 E Street 2
Alexandria Center® for Life Science – Long Island City 1 Alexandria Center® for Life Science – Fenway 1
3160 Porter Drive 1 704 Quince Orchard Road 1
The Arsenal on the Charles 11 Other 26
700 Quince Orchard Road 1 66
Alexandria Center® for Life Science – Durham Unconsolidated real estate JVs 5
3 Properties held for sale 4
840 Winter Street 1 Total properties excluded from same properties
Other/San Diego 1 110
20400 Century Boulevard 1 Same properties 250
21 Total properties in North America as of<br><br>March 31, 2021 360
Redevelopment – placed into
service after January 1, 2020 Properties
9877 Waples Street 1
1

Stabilized occupancy date

The stabilized occupancy date represents the estimated date on which the project is expected to reach occupancy of 95% or greater.

Tenant recoveries

Tenant recoveries represent revenues comprising reimbursement of real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses and earned in the period during which the applicable expenses are incurred and the tenant’s obligation to reimburse us arises.

| Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 | 61 | | --- | --- || Definitions and Reconciliations (continued) | | --- | | March 31, 2021 |

We classify rental revenues and tenant recoveries generated through the leasing of real estate assets within revenue in income from rentals in our consolidated statements of operations. We provide investors with a separate presentation of rental revenues and tenant recoveries in “Same Property Performance” of this Supplemental Information because we believe it promotes investors’ understanding of our operating results. We believe that the presentation of tenant recoveries is useful to investors as a supplemental measure of our ability to recover operating expenses under our triple net leases, including recoveries of utilities, repairs and maintenance, insurance, property taxes, common area expenses, and other operating expenses, and of our ability to mitigate the effect to net income for any significant variability to components of our operating expenses.

The following table reconciles income from rentals to tenant recoveries:

Three Months Ended
(In thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Income from rentals $ 478,695 $ 461,335 $ 543,412 $ 435,856 $ 437,605
Rental revenues (370,233) (353,950) (438,393) (341,555) (337,942)
Tenant recoveries $ 108,462 $ 107,385 $ 105,019 $ 94,301 $ 99,663

Total equity capitalization

Total equity capitalization is equal to the outstanding shares of common stock multiplied by the closing price on the last trading day at the end of each period presented.

Total market capitalization

Total market capitalization is equal to the sum of total equity capitalization and total debt.

Unencumbered net operating income as a percentage of total net operating income

Unencumbered net operating income as a percentage of total net operating income is a non-GAAP financial measure that we believe is useful to investors as a performance measure of the results of operations of our unencumbered real estate assets as it reflects those income and expense items that are incurred at the unencumbered property level. Unencumbered net operating income is derived from assets classified in continuing operations, which are not subject to any mortgage, deed of trust, lien, or other security interest, as of the period for which income is presented.

The following table summarizes unencumbered net operating income as a percentage of total net operating income:

Three Months Ended
(Dollars in thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Unencumbered net operating income $ 330,160 $ 315,586 $ 388,575 $ 296,358 $ 295,001
Encumbered net operating income 11,801 11,367 16,024 16,687 15,815
Total net operating income $ 341,961 $ 326,953 $ 404,599 $ 313,045 $ 310,816
Unencumbered net operating income as a percentage of total net operating income 97% 97% 96% 95% 95%

Weighted-average interest rate for capitalization of interest

The weighted-average interest rate required for calculating capitalization of interest pursuant to GAAP represents a weighted-average rate based on the rates applicable to borrowings outstanding during the period, including expense/income related to interest rate hedge agreements, amortization of loan fees, amortization of debt premiums (discounts), and other bank fees. A separate calculation is performed to determine our weighted-average interest rate for capitalization for each month. The rate will vary each month due to changes in variable interest rates, outstanding debt balances, the proportion of variable-rate debt to fixed-rate debt, the amount and terms of interest rate hedge agreements, and the amount of loan fee and premium (discount) amortization.

The following table presents the weighted-average interest rate for capitalization of interest:

Three Months Ended
3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Weighted-average interest rate for capitalization of interest 3.44% 3.66% 3.64% 4.03% 3.80%

Weighted-average shares of common stock outstanding – diluted

From time to time, we enter into capital market transactions, including forward equity sales agreements (“Forward Agreements”), to fund acquisitions, to fund construction of our highly leased development and redevelopment projects, and for general working capital purposes. We are required to consider the potential dilutive effect of our forward equity sales agreements under the treasury stock method while the forward equity sales agreements are outstanding. As of March 31, 2021, we had Forward Agreements outstanding to sell an aggregate of 1.5 million shares of common stock.

The weighted-average shares of common stock outstanding used in calculating EPS – diluted, FFO per share – diluted, and FFO per share – diluted, as adjusted, during each period are calculated as follows:

Three Months Ended
(In thousands) 3/31/21 12/31/20 9/30/20 6/30/20 3/31/20
Weighted-average of common stock outstanding – basic 137,319 133,688 124,901 124,333 121,433
Forward Agreements 369 139 927 115 352
Weighted-average of common stock outstanding – diluted 137,688 133,827 125,828 124,448 121,785
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021 62
--- ---